Document:

exv10w1

Exhibit 10.1

Confidential Materials omitted and filed separately with the

Securities and Exchange Commission. Asterisks denote omissions.

Final Agreement June 1, 2010

 

Second Amendment

     THIS SECOND AMENDMENT (the “Amendment”) is made as of June 1, 2010 by and
between ASTRAZENECA AB, a company organized under the laws of Sweden having its principal place of
business at SE-151 85 Södertälje, Sweden (“ASTRAZENECA”) and THE MEDICINES COMPANY, a company
organized under the laws of Delaware having its principal place of business at 8 Sylvan Way,
Parsippany, NJ 07054 (“TMC”). ASTRAZENECA and TMC are sometimes referred to herein individually as
a “Party” and collectively as the “Parties.”

RECITALS

     WHEREAS, ASTRAZENECA and TMC are the parties to that certain License Agreement
entered into as of the 18th day of December 2003, as heretofore amended effective as of
July 6, 2007, the “Agreement”, relating to ASTRAZENECA’s selective inhibition ADP compound known as
Cangrelor.

     WHEREAS, ASTRAZENECA and TMC desire to amend the Agreement on the terms set forth below.

     NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants
contained herein, the Parties, intending to be legally bound, agree as follows:

	1	 	The Agreement is amended to add the following new definitions.
	 
	1.1	 	“Amendment Effective Date” shall mean June 1, 2010.
	 
	1.2	 	“Bridging Study” shall have the meaning set forth in Article 3.4.3 (b).

1

 

	1.3	 	“Cangrelor” shall mean the Compound in such formulation for intravenous administration as
has been developed by TMC.
	 
	1.4	 	“CHAMPION-PHOENIX Study” shall mean a repeat phase III prospective, randomised, double
blind, standard clopidogrel care controlled, parallel group, superiority study in which the
primary objective is to demonstrate that the efficacy of Cangrelor (combined with 600mg of
clopidogrel) is superior to that of usual care, in patients requiring percutaneous coronary
intervention (PCI) as measured by a composite of all cause mortality, myocardial infarction
(MI), IDR and stent thrombosis which will be performed under US IND 56,812.
	 
	1.5	 	“Change of Control” means an event in which:

	 	   1.5.1	 	[**] or any of its Affiliates or a successor of any such entity (collectively
referred to herein as ” [**]”) (a)comes in possession, directly or indirectly, of
the power to direct the management or polices of TMC, whether through ownership of
voting securities, by contract or otherwise, or (b) acquires beneficial ownership,
directly or indirectly, of securities of TMC representing more than fifty percent
(50%) of the voting power of the then outstanding securities of TMC, or
	 
	 	   1.5.2	 	TMC sells to [**], directly or indirectly, in one or more transactions, properties
or assets (i) representing more than fifty percent (50%) of TMC’s consolidated total
assets or (ii) from which more than fifty percent (50%) of TMC’s consolidated
operating income for its most recent fiscal year was derived.

	1.6	 	“Ticagrelor Product” shall mean ASTRAZENECA’s pharmaceutical product containing the
pharmaceutical compound known as ticagrelor, a reversibly binding oral P2Y12 adenosine
diphosphate (ADP) receptor antagonist.

2

 

	2	 	The following Articles of the Agreement are hereby amended as follows:

	2.1	 	A new Article 3.3.4 is added reading:

     “ASTRAZENECA will not be able to provide any regulatory assistance under the Agreement after
December 31, 2010 and, notwithstanding anything set forth in the Agreement, any remaining
obligations of ASTRAZENECA to assist TMC shall then cease.”

	2.2	 	A new Article 3.4.3 is added reading:

“Without prejudice to the generality of Articles 3.4.1 and 3.4.2, as a part of the development of
Cangrelor TMC shall:

	 	(a)	 	as soon as practicable following the Amendment Effective Date, initiate the
CHAMPION-PHOENIX Study and use Commercially Reasonable Efforts to conduct the study in a
diligent and expeditious manner. Without prejudice to the immediately preceding sentence,
should ASTRAZENECA require by giving notice no later than two (2) months of the Amendment
Effective Date, TMC shall, whichever ASTRAZENECA may require, include in the
CHAMPION-PHOENIX Study (i) such number of patients from either of Korea or Thailand, or
both, that TMC has specified by giving notice to ASTRAZENECA that TMC desires to include in
patient enrolment in the CHAMPION-PHOENIX Study, and/or (ii) such number of patients from
either of China or Taiwan, or both, that ASTRAZENECA at its discretion considers sufficient
to obtain approved NDAs in such countries. The costs for any patient included as described
under (i) shall be carried by TMC and the costs for any patient included as described under
(ii) shall be carried by ASTRAZENECA. TMC shall give such notice of number of
patients mentioned under (i) within two (2) weeks of the Amendment Effective Date but,
without prejudice to ASTRAZENECA’s rights hereunder in this regard, ASTRAZENECA shall
always have the right to provide its notice insofar it relates to the countries under (i)
within no less than six (6) weeks of the date of receipt of TMC’s notice.
	 
	 	 	 	Notwithstanding the foregoing, ASTRAZENECA shall have the right to withdraw its request
under (ii) at any time regarding either or both countries. In case of such ASTRAZENECA’s
withdrawal, TMC shall as soon as reasonably possible, with full account taken to patient
safety, study ethics and Good Clinical Practice, terminate the CHAMPION-PHOENIX Study in
either or both, as notified by ASTRAZENECA, of those countries. ASTRAZENECA shall then carry
no further liability for any costs stated

3

 

	 	 	 	in this Article 3.4.3 (a) other than those relating to reasonably non-cancellable
expenses committed to by TMC at the date of ASTRAZENECA’s withdrawal of such request for
completing the study in such country in accordance with the immediately preceding sentence.
	 
	 	 	 	For the purpose of this Article 3.4.3 a) “costs” shall mean all expenses paid relating
specifically to the CHAMPION-PHOENIX Study to Third Parties (or payable to Third Parties and
accrued in accordance with TMC’s accounting standards as generally and consistently applied
throughout TMC’s organization) by TMC, and which costs cannot be reasonably incurred by TMC
using its own internal resource or FTEs or consultants otherwise engaged by TMC in
connection with activities outside the scope of the Agreement; and
	 
	 	(b)	 	perform a pharmacokinetics/pharmacodynamics study with Cangrelor and the Ticagrelor Product
(the “Bridging Study”). The Bridging Study shall be completed before the submission of the
first NDA for Cangrelor with the aim that the results could be included in all NDAs and other
regulatory submissions in the Territory. TMC shall provide ASTRAZENECA with proposals for the
study protocol and budget for performing the Bridging Study and the Parties shall in good
faith discuss and agree upon the definitive protocol and budget. ASTRAZENECA shall have the
right to request expansions or additional arms of the Bridging Study and TMC will include
such reasonable expansions or additional arms in the study. The Parties shall jointly analyse
and interpret the results of the Bridging Study and in good faith discuss the label strategy.
TMC shall bear the costs for performing the study, including expansions or additional arms
required by ASTRAZENECA, up to U.S. Dollars one million ($1,000, 000) (the “Cap”). ASTRAZENECA
will reimburse TMC for verified costs exceeding the Cap incurred as a result of the
performance of the Bridging Study, including expansions or additional arms required by
ASTRAZENECA. For the purpose of this Article 3.4.3 b) “costs” shall mean all expenses paid
relating specifically to the Bridging Study to Third Parties (or payable to Third Parties and
accrued in accordance with TMC’s accounting standards as generally and consistently applied
throughout TMC’s organization) by TMC, and which costs cannot be reasonably incurred by TMC
using its own internal resource or FTEs or

4

 

	 	 	consultants otherwise engaged by TMC in connection with activities
outside the scope of the Agreement.
	 
	2.3	 	Article 3.7.2 is modified to read as follows:
	 
	 	 	“TMC shall use Commercial Reasonable Efforts to diligently and expeditiously file NDAs in
the United States and all other Major Markets.”
	 
	2.4	 	Article 3.7.3 is deleted.
	 
	2.5	 	The reference to Article 3.7.2 (a) in Article 3.8.1 b) is amended to refer to Article 3.7.2,
as amended in this Amendment. Article 3.8.1 c) is deleted.
	 
	2.6	 	A new Article 3.10 is added reading.
	 
	 	 	“ASTRAZENECA shall have the option to obtain from TMC critical care
strategic and secondary detail support for the promotion of the
Ticagrelor Product in the United States on a fee-for-service basis on
a then prevailing market rate. If and when ASTRAZENECA exercises this
option, the Parties shall in good faith discuss and agree (subject to
all applicable laws and regulations) upon the detailed terms for a
Commercial Assistance Agreement under which TMC shall provide to
ASTRAZENECA the support described above based on the terms attached
hereto Schedule 1.”
	 
	2.7	 	A new Article 5.1.5. is added reading:
	 
	 	 	“In addition to Articles 5.1.1 to 5.1.4, TMC shall prepare and
maintain complete and accurate records and reports regarding the
development of Cangrelor. ASTRAZENECA shall have the right from time
to time and upon reasonable prior notice to TMC to examine TMC’s
records regarding such activities. TMC shall provide ASTRAZENECA with
a quarterly report on the progress in the development of Cangrelor in
the Territory in order to keep ASTRAZENECA informed of its progress.
Such report shall cover general information on TMC’s development
activities in the previous Quarter, a summary of the activities
planned in the next Quarter, and a timetable of planned and actual
submissions for NDAs. Notwithstanding the foregoing, TMC shall provide
to ASTRAZENECA

5

 

	 	 	interim analysis, if available, and summaries of the results of the CHAMPION-PHOENIX Study
and the Bridging Study as well as other studies performed by or on behalf of TMC in relation
to Cangrelor promptly upon completion of the studies. AstraZeneca shall only use the
information provided pursuant to this Article 5.1.5 for the purpose of ensuring that TMC is
complying with its obligations under the Agreement and may only share such information
internally consistent with Article 11.1.”.
	 
	2.8	 	A new Article 6.1 A is added reading:
	 
	 	 	“Amendment Fee.
	 
	 	 	In consideration of the agreements set forth in this Amendment, TMC
shall pay to ASTRAZENECA a non-refundable amendment fee of U.S.
Dollars [**] within thirty (30) calendar days
following the Amendment Effective Date.”
	 
	2.9	 	A new Article 6.1.4 is added reading:
	 
	 	 	“TMC shall make each of the milestone payments indicated below to ASTRAZENECA when
cumulative Net Sales across all indications in the Territory first reach the specified
dollar values in any Calendar Year. For clarity, each such milestone payment shall be
non-refundable against any other payment due under this agreement:

	 	 	 
	Annual Net Sales in the Territory	 	Milestone payment
	USD [**] ($[**])
	 	USD [**] ($[**])
	 
	 	 
	USD [**] ($[**])
	 	USD [**] ($[**])
	 
	 	 
	USD [**] ($[**])
	 	USD [**] ($[**])
	 
	 	 
	USD [**] ($[**])
	 	USD [**] ($[**])

The sales related payments shall be paid at the end of the Quarter in which the relevant Net Sales
threshold was achieved at the same time as TMC pays the royalties due for that Quarter. Each

6

 

milestone in this section shall be paid only once, and the maximum total amount of the payment
to ASTRAZENECA pursuant to this Article 6.1.4 shall be fifty million dollars ($50,000,000). For
clarity, if cumulative annual Net Sales of Products in a calendar year satisfies more than one
milestone event set forth above, the payment shall be made for each such payment event that has
been satisfied.”

	2.10	 	The table under Article 6.2.1 is modified to read as follows:

	 	 	 
	Annual Net Sales in the Territory	 	Royalty Rate
	a) up to USD [**] ($ [**])

	 	[**] percent ([**]%)
	 
	 	 
	b) above USD [**] ($[**]) and up to USD [**] ($[**])

	 	[**] percent ([**]%)
	 
	 	 
	c) above USD [**] ($[**]) and up to USD [**] ($[**])

	 	[**] percent ([**]%)
	 
	 	 
	d) above USD [**] ($[**]) and up to USD [**] ($[**])

	 	[**] percent ([**]%)
	 
	 	 
	e) above USD [**] ($[**])

	 	[**] percent ([**]%)

	2.11	 	Wire Transfer Instructions

	 	 	 	Article 6.9.1 is amended as follows:

    All payments to AstraZeneca pursuant to this Agreement shall be remitted from the
United States by wire transfer to the following bank account of AstraZeneca or such
other account as AstraZeneca may designate in writing to TMC:

	 	 	 	BANK ACCOUNT

	 	 	 	 	 

	 

	 	Beneficiary:
	 	AstraZeneca AB
	 
	 	 	 	 
	 

	 	Bank Name:
	 	[**]
	 
	 	 	 	 
	 

	 	Account Number:
	 	[**]
	 
	 	 	 	 
	 

	 	Swift:
	 	[**]
	 
	 	 	 	 
	 

	 	IBAN:
	 	[**]

7

 

	2.12	 	A new Article 14.3 A is added reading:

“Termination for Change of Control of TMC. In the event that TMC
undergoes a Change of Control during such time as [**] is developing
or commercialising the pharmaceutical product known as [**] in any
country in the world, TMC shall promptly notify ASTRAZENECA in
writing and ASTRAZENECA shall have the right to terminate the
Agreement by written notice to TMC within one hundred twenty (120)
days following the receipt of the notice from TMC. The termination
shall become effective upon TMC’s receipt of the termination
notice..”
	 
	2.13	 	The second paragraph of Article 15.1 is modified to read:

“Upon termination of this Agreement by TMC pursuant to Article 14.2
or by ASTRAZENECA pursuant to Articles 14.3 or 14.3A or by
ASTRAZENECA in a certain country pursuant to Article 3.8, the license
granted under Article 2.1 regarding the country (ies) contemplated by
the termination concerned shall cease, and TMC shall regarding the
Territory or country concerned, whichever is applicable:”
	 
	3	 	No Other Amendments. Except as expressly amended hereby, all of the terms and
conditions of the Agreement shall remain in full force and effect.
	 
	4	 	Mutual Representations and Warranties. Each Party represents and warrants to the
other as of the date hereof that:

     (a) Corporate Power. It is duly organized, validly existing and in good
standing under the laws of its jurisdiction of incorporation or formation, and has full
corporate power and authority to enter into this Amendment and to carry out the provisions
hereof.

     (b) Due Authorization. It is duly authorized to execute and deliver this
Amendment and to perform its obligations hereunder, and the person executing this

8

 

Amendment on its behalf has been duly authorized to do so by all requisite corporate
action.

     (c) Binding Agreement. This Amendment is legally binding upon it and
enforceable against it in accordance with its terms.

	5	 	Headings.
The headings used in this Amendment have been inserted for convenience of
reference only and do not define or limit the provisions hereof.
	 
	6	 	Entire Agreement.
This Amendment, together with the Agreement, constitutes the
entire agreement between the Parties with respect to the subject matter of the Agreement. The
Agreement together with this Amendment supersedes all prior agreements, whether written or
oral, with respect to the subject matter of the Agreement, as amended. Each Party confirms
that it is not relying on any statements, representations, warranties or covenants of any
person (whether a Party to this Agreement or not) except as specifically set out in the
Agreement as amended. Nothing in this Amendment is intended to limit or exclude any liability
for fraud. All Schedules referred to in this Amendment are intended to be and are hereby
specifically incorporated into and made a part of the Agreement. The Parties hereby agree that
subject to the modifications specifically stated in this Amendment, all terms and conditions
of the Agreement shall remain in full force and effect.

9

 

	7	 	Counterparts; Facsimile Signatures. 
This Amendment may be executed in two (2) or
more counterparts, each of which shall be deemed an original, but all of which together shall
constitute one (1) and the same instrument. This Amendment may be executed by facsimile
signatures and such signatures shall be deemed to bind each Party as if they were original
signatures.
	 
	8	 	Governing Law and Disputes. 
This Amendment shall be governed by the laws of the
Agreement and any dispute arising out of or in connection with this Amendment shall be settled
in accordance with the procedure provided for in the Agreement.

[Signature page follows.]

10

 

     In Witness Whereof, the Parties have caused this Amendment to be executed by their
duly authorized representatives as of the day and year first above written.

	 	 	 	 	 	 	 	 	 
	THE MEDICINES COMPANY	 	 	 	ASTRAZENECA AB(PUBL)
	 
	 	 	 	 	 	 	 	 
	By:

	 	/s/ Clive Meanwell
	 	 	 	By:
	 	/s/ Anders Burén
	 

	 	 
	 	 	 	 	 	 
	 

	 	Name: Clive Meanwell
	 	 	 	 	 	Name: Anders Burén
	 

	 	Title: Chairman & CEO
	 	 	 	 	 	Title: Authorized Signatory

11exv4w2

Exhibit 4.2

TELEFLEX INCORPORATED

as Issuer

WELLS FARGO BANK, N.A.

as Trustee

 

First Supplemental Indenture

Dated as of August 9, 2010

to the Indenture dated as

of

August 2, 2010

 

3.875% Convertible Senior Subordinated Notes due 2017

 

 

TABLE OF CONTENTS

	 	 	 	 	 	 	 
	 	 	 	 	PAGE
	 	 	 
	 	 	 	 
	ARTICLE 1. DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION	 	 	1	 
	 	 	 
	 	 	 	 
	Section 1.01
	 	Scope of Supplemental Indenture

	 	 	1	 
	Section 1.02
	 	Definitions

	 	 	2	 
	Section 1.03
	 	References to Interest

	 	 	16	 
	 	 	 
	 	 	 	 
	ARTICLE 2. THE SECURITIES	 	 	16	 
	 	 	 
	 	 	 	 
	Section 2.01
	 	Title and Terms; Payments

	 	 	16	 
	Section 2.02
	 	Book-Entry Provisions for Global Notes

	 	 	17	 
	Section 2.03
	 	Reporting Requirement

	 	 	18	 
	Section 2.04
	 	Repurchase and Cancellation

	 	 	19	 
	 	 	 
	 	 	 	 
	ARTICLE 3. FUNDAMENTAL CHANGES AND PURCHASES THEREUPON	 	 	19	 
	 	 	 
	 	 	 	 
	Section 3.01
	 	Purchase at Option of Holders Upon a Fundamental Change

	 	 	19	 
	Section 3.02
	 	Effect of Fundamental Change Purchase Notice

	 	 	21	 
	Section 3.03
	 	Withdrawal of Fundamental Change Purchase Notice

	 	 	21	 
	Section 3.04
	 	Deposit of Fundamental Change Purchase Price

	 	 	22	 
	Section 3.05
	 	Notes Purchased in Whole or in Part

	 	 	22	 
	Section 3.06
	 	Covenant to Comply With Applicable Laws Upon Purchase of Notes

	 	 	22	 
	Section 3.07
	 	Repayment to the Company

	 	 	23	 
	 	 	 
	 	 	 	 
	ARTICLE 4. CONVERSION	 	 	23	 
	 	 	 
	 	 	 	 
	Section 4.01
	 	Right to Convert

	 	 	23	 
	Section 4.02
	 	Conversion Procedures

	 	 	25	 
	Section 4.03
	 	Settlement Upon Conversion

	 	 	27	 
	Section 4.04
	 	Adjustment of Conversion Rate

	 	 	29	 
	Section 4.05
	 	Certain Other Adjustments

	 	 	39	 
	Section 4.06	 	Adjustment
to Conversion Rate Upon Conversion in Connection with a Make-Whole
Fundamental Change
	 	 	39	 
	Section 4.07
	 	Effect of Recapitalization, Reclassification, Consolidation, Merger or Sale

	 	 	40	 
	Section 4.08
	 	Taxes on Shares Issued

	 	 	43	 
	Section 4.09
	 	Reservation of Shares; Shares to be Fully Paid; Compliance With Governmental
Requirements; Listing of Common Stock

	 	 	43	 
	Section 4.10
	 	Responsibility of Trustee

	 	 	43	 
	Section 4.11
	 	Notice to Holders Prior to Certain Actions

	 	 	44	 
	Section 4.12
	 	Stockholder Rights Plan

	 	 	44	 
	 	 	 
	 	 	 	 
	ARTICLE 5. REMEDIES	 	 	45	 
	 	 	 
	 	 	 	 
	Section 5.01
	 	Events of Default

	 	 	45	 
	Section 5.02
	 	Acceleration
	 	 	46	 
	Section 5.03
	 	Additional Interest

	 	 	47	 
	Section 5.04
	 	Waiver; Unconditional Right of Holders to Receive Amounts Due Upon Conversion

	 	 	47	 
	Section 5.05
	 	Notice of Defaults

	 	 	48	 
	Section 5.06
	 	Overdue Payments

	 	 	48	 

i 

 

	 	 	 	 	 	 	 
	 	 	 	 	PAGE
	ARTICLE 6. SATISFACTION AND DISCHARGE	 	 	48	 
	 	 	 
	 	 	 	 
	Section 6.01
	 	Satisfaction and Discharge of the Supplemental Indenture

	 	 	48	 
	Section 6.02
	 	Deposited Monies to Be Held in Trust by Trustee

	 	 	49	 
	Section 6.03
	 	Paying Agent to Repay Monies Held

	 	 	49	 
	Section 6.04
	 	Return of Unclaimed Monies

	 	 	49	 
	Section 6.05
	 	Reinstatement

	 	 	50	 
	 	 	 
	 	 	 	 
	ARTICLE 7. SUPPLEMENTAL INDENTURES	 	 	50	 
	 	 	 
	 	 	 	 
	Section 7.01
	 	Supplemental Indentures Without Consent of Holders

	 	 	50	 
	Section 7.02
	 	Supplemental Indentures With Consent of Holders

	 	 	51	 
	Section 7.03
	 	Notice of Amendment or Supplement

	 	 	52	 
	 	 	 
	 	 	 	 
	ARTICLE 8. SUCCESSOR COMPANY	 	 	52	 
	 	 	 
	 	 	 	 
	Section 8.01
	 	Consolidation, Merger and Sale of Assets

	 	 	52	 
	Section 8.02
	 	Successor Person Substituted

	 	 	53	 
	Section 8.03
	 	Opinion of Counsel to Be Given to Trustee

	 	 	53	 
	 	 	 
	 	 	 	 
	ARTICLE 9. MISCELLANEOUS	 	 	53	 
	 	 	 
	 	 	 	 
	Section 9.01
	 	Governing Law

	 	 	53	 
	Section 9.02
	 	Legal Holidays

	 	 	54	 
	Section 9.03
	 	No Security Interest Created

	 	 	54	 
	Section 9.04
	 	Trust Indenture Act

	 	 	54	 
	Section 9.05
	 	Benefits of Supplemental Indenture

	 	 	54	 
	Section 9.06
	 	Calculations

	 	 	54	 
	Section 9.07
	 	Effect of Headings and Table of Contents

	 	 	54	 
	Section 9.08
	 	Execution in Counterparts

	 	 	54	 
	Section 9.09
	 	Separability Clause

	 	 	54	 
	Section 9.10
	 	Ratification of Original Indenture

	 	 	54	 
	Section 9.11
	 	The Trustee

	 	 	55	 
	Section 9.12
	 	No Recourse Against Others

	 	 	55	 
	 	 	 
	 	 	 	 
	ARTICLE 10. SUBORDINATION	 	 	55	 
	 	 	 
	 	 	 	 
	Section 10.01
	 	Agreement to Subordinate

	 	 	55	 
	Section 10.02
	 	Liquidation; Dissolution; Bankruptcy

	 	 	55	 
	Section 10.03
	 	Default on Designated Senior Indebtedness

	 	 	56	 
	Section 10.04
	 	Acceleration of Notes

	 	 	57	 
	Section 10.05
	 	When Distribution Must Be Paid Over

	 	 	57	 
	Section 10.06
	 	Notice by Company

	 	 	57	 
	Section 10.07
	 	Subrogation

	 	 	57	 
	Section 10.08
	 	Relative Rights

	 	 	58	 
	Section 10.09
	 	Subordination May Not Be Impaired by Company

	 	 	58	 
	Section 10.10
	 	Distribution or Notice to Representative or Holders of Senior Indebtedness

	 	 	58	 
	Section 10.11
	 	Rights of Trustee and Paying Agent

	 	 	59	 
	Section 10.12
	 	Authorization to Effect Subordination; Filing Proof of Claim

	 	 	59	 
	Section 10.13
	 	Reliance and Amendments

	 	 	59	 
	Section 10.14
	 	No Layering

	 	 	60	 
	Section 10.15
	 	No Waiver of Subordination Provisions

	 	 	60	 
	 	 	 
	 	 	 	 
	EXHIBIT

	 	 	 
	 	 	 	 
	Exhibit A
	 	Form of Note

	 	 	A-1	 

ii 

 

     FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of August 9, 2010,
between Teleflex Incorporated, a Delaware corporation (the “Company”), and Wells Fargo Bank, N.A,
(the “Trustee”) as trustee under the Indenture dated as of August 2, 2010, between the Company and
the Trustee (as amended or supplemented from time to time in accordance with the terms thereof, the
"Original Indenture”).

RECITALS OF THE COMPANY

     WHEREAS, the Company executed and delivered the Original Indenture to the Trustee to provide,
among other things, for the issuance, from time to time, of the Company’s unsecured Securities, in
an unlimited aggregate principal amount, in one or more series to be established by the Company
under, and authenticated and delivered as provided in, the Original Indenture;

     WHEREAS, Section 9.1(j) of the Original Indenture provides for the Company and the Trustee to
enter into supplemental indentures to the Original Indenture to establish the form and terms of
Securities of any series as contemplated by Section 2.1 of the Original Indenture;

     WHEREAS, the Board of Directors has duly adopted resolutions authorizing the Company to
execute and deliver this Supplemental Indenture;

     WHEREAS, pursuant to the terms of the Original Indenture, the Company desires to establish a
new series of its Securities to be known as its “3.875% Convertible Senior Subordinated Notes due
2017” (the “Notes”), the form and substance of such Notes and the terms, provisions and conditions
thereof to be set forth as provided in the Original Indenture and this Supplemental Indenture;

     WHEREAS, the Form of Note, the certificate of authentication to be borne by each Note and the
Form of Notice of Conversion, Form of Fundamental Change Purchase Notice and Form of Assignment and
Transfer contemplated under the terms of the Notes are to be substantially in the forms hereinafter
provided; and

     WHEREAS, the Company has requested that the Trustee execute and deliver this Supplemental
Indenture, and all requirements necessary to make (i) this Supplemental Indenture a valid
instrument in accordance with its terms, and (ii) the Notes, when executed by the Company and
authenticated and delivered by the Trustee, the valid obligations of the Company have been
performed, and the execution and delivery of this Supplemental Indenture have been duly authorized
in all respects.

     NOW, THEREFORE, THIS SUPPLEMENTAL INDENTURE WITNESSETH, for and in consideration of the
premises and the purchases of the Notes by the Holders thereof, it is mutually agreed, for the
benefit of the Company and the equal and proportionate benefit of all Holders of the Notes, as
follows:

ARTICLE 1.

DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION

               Section 1.01 Scope of Supplemental Indenture. The changes, modifications and supplements to the Original Indenture effected by this
Supplemental Indenture

1

 

shall be applicable only with respect to, and shall only govern the terms
of, the Notes, which may be issued from time to time, and shall not apply to any other Securities
that may be issued under the Original Indenture unless a supplemental indenture with respect to
such other Securities specifically incorporates such changes, modifications and supplements. The
provisions of this Supplemental Indenture shall supersede any corresponding provisions in the
Original Indenture.

               Section 1.02 Definitions. For all purposes of the Indenture, except as otherwise expressly provided or unless the
context otherwise requires:

     (i) the terms defined in this Article 1 shall have the meanings assigned to them in
this Article 1 and include the plural as well as the singular;

     (ii) all words, terms and phrases defined in the Original Indenture (but not otherwise
defined herein) shall have the same meanings as in the Original Indenture;

     (iii) all other terms used herein that are defined in the Trust Indenture Act, either
directly or by reference therein, shall have the meanings assigned to them in the Trust
Indenture Act;

     (iv) all accounting terms not otherwise defined herein shall have the meanings assigned
to them in accordance with generally accepted accounting principles, and, except as
otherwise herein expressly provided, the term “generally accepted accounting principles”
with respect to any computation required or permitted hereunder shall mean such accounting
principles as are generally accepted at the date of this instrument; and

     (v) the words “herein,” “hereof” and “hereunder” and other words of similar import
refer to this Supplemental Indenture as a whole and not to any particular Article, Section
or other subdivision.

     “Additional Interest” has the meaning specified in Section 5.03.

     “Additional Notes” has the meaning specified in Section 2.01.

     “Additional Shares” has the meaning specified in Section 4.06(a).

     “Adjustment Event” means, any event that requires an adjustment to the Conversion Rate
pursuant to Sections 4.04(a), (b), (c), (d) or (e).

     “Affiliate” of any specified person means any other person directly or indirectly controlling
or controlled by or under direct or indirect common control with such specified person. For
purposes of this definition, “control,” as used with respect to any person, means the possession,
directly or indirectly, of the power to direct or cause the direction of the management or policies
of such person, whether through the ownership of voting securities, by agreement or
otherwise. For purposes of this definition, the terms “controlling,” “controlled by” and
“under common control with” have correlative meanings.

     “Agent Members” has the meaning specified in Section 2.02(a).

2

 

     “Bankruptcy Law” means Title 11, U.S. Code or any similar federal or state law for the relief
of debtors.

     “Bid Solicitation Agent” means the Company or such other person (including the Trustee) as may
be appointed, from time to time, by the Company to solicit bids for the Trading Price of the Notes
in accordance with Section 4.01(b)(2). The Trustee shall initially act as the Bid Solicitation
Agent.

     “Board of Directors” means:

     (1) with respect to a corporation, the board of directors of the corporation or any
committee thereof duly authorized to act on behalf of such board;

     (2) with respect to a partnership, the Board of Directors of the general partner of the
partnership;

     (3) with respect to a limited liability company, the managing member or members or any
controlling committee of managing members thereof; and

     (4) with respect to any other person, the board or committee of such person serving a
similar function.

     “Business Day” means, with respect to any Note, any day other than a Saturday, a Sunday or a
day on which the Federal Reserve Bank of New York is authorized or required by law or executive
order to close or to be closed.

     “Capital Lease Obligations” of any person means the obligations of such person to pay rent or
other amounts under any lease of (or other arrangement conveying the right to use) real or personal
property, or a combination thereof, which obligations are required to be classified and accounted
for as capital leases on a balance sheet of such person under GAAP, and the amount of such
obligations shall be the capitalized amount thereof determined in accordance with GAAP.

     “Cash Settlement” has the meaning specified in Section 4.03(a).

     “Cash Settlement Averaging Period” with respect to any Note being converted means:

     (1) with respect to any Conversion Date occurring during the period beginning on March
30, 2017, the 80 consecutive Trading Days beginning on, and including, the 82nd Scheduled
Trading Day prior to the Stated Maturity; and

     (2) in all other cases, the 80 consecutive Trading Day period beginning on, and
including, the third Trading Day immediately following the related Conversion Date.

     “Clause A Distribution” has the meaning specified in Section 4.04(c).

     “Clause B Distribution” has the meaning specified in Section 4.04(c).

     “Clause C Distribution” has the meaning specified in Section 4.04(c).

3

 

     “close of business” means 5:00 p.m., New York City time.

     “Code” means the U.S. Internal Revenue Code of 1986, as amended.

     “Combination Settlement” has the meaning specified in Section 4.03(a).

     “Common Equity” of any person means Capital Stock of such person that is generally entitled
(a) to vote in the election of directors of such person or (b) if such person is not a corporation,
to vote or otherwise participate in the selection of the governing body, partners, managers or
others that will control the management or policies of such person.

     “Common Stock” means the common stock of the Company, par value $1 per share, at the date of
this Supplemental Indenture, or such other Reference Property into which the Company’s common stock
is changed pursuant to Section 4.07.

     “Company” has the meaning specified in the first paragraph of this Supplemental Indenture.

     “Conversion Agent” means the Trustee or such other office or agency designated by the Company
where Notes may be presented for conversion. The Trustee shall initially be the Conversion Agent.

     “Conversion Date” has the meaning specified in Section 4.02(b).

     “Conversion Notice” has the meaning specified in Section 4.02(b)(1).

     “Conversion Obligation” has the meaning specified in Section 4.01(a).

     “Conversion Price” means, in respect of each Note, as of any date, $1,000, divided by the
Conversion Rate as of such date.

     “Conversion Rate” means initially 16.3084 shares of Common Stock per $1,000 principal amount
of Notes, subject to adjustment as set forth herein.

     “Corporate Trust Office” means the address of the Trustee specified in Section 12.2 of the
Original Indenture or such other address as to which the Trustee may give notice to the Company.

     “Credit Facilities” means that certain credit agreement, dated as of October 1, 2007, by and
among the Company, the guarantors party thereto, the lenders party thereto, JPMorgan Chase Bank,
N.A., as administrative agent and collateral agent, and Bank of America, N.A., as syndication
agent, including any related notes, guarantees, collateral documents, instruments and agreements
executed in connection therewith, and, in each case, as amended, restated, modified,
renewed, refunded, replaced in any manner (whether upon or after termination or otherwise) or
refinanced (including by means of sales of debt securities) in whole or in part from time to time.

     “Custodian” means the Trustee, as custodian with respect to the Notes (so long as the Notes
constitute Global Notes), or any successor entity.

4

 

     “Daily Conversion Value” means, for each of the 80 consecutive Trading Days during the
applicable Cash Settlement Averaging Period, one-eightieth (1/80th) of the product of (a) the
applicable Conversion Rate on such Trading Day and (b) the Daily VWAP of the Common Stock on such
Trading Day.

     “Daily Deliverable Shares” means, for each of the 80 consecutive Trading Days during the
applicable Cash Settlement Averaging Period, a number of shares of Common Stock equal to (i) the
difference between the Daily Conversion Value for such Trading Day and the Daily Specified Dollar
Amount, divided by (ii) the Daily VWAP for such Trading Day.

     “Daily Principal Portion” means, for each of the 80 consecutive Trading Days during the
applicable Cash Settlement Averaging Period, an amount of cash equal to the lesser of (i) the Daily
Specified Dollar Amount and (ii) the Daily Conversion Value for such Trading Day.

     “Daily Settlement Amount” means, for each of the 80 consecutive Trading Days during the
applicable Cash Settlement Averaging Period, an amount consisting of:

     (a) the Daily Principal Portion; and

     (b) if the Daily Conversion Value for such Trading Day exceeds the Daily Specified
Dollar Amount, the Daily Deliverable Shares.

     “Daily Specified Dollar Amount” means an amount equal to the Specified Dollar Amount (if any),
divided by 80.

     “Daily VWAP” means, for each Trading Day, the per share volume-weighted average price as
displayed under the heading “Bloomberg VWAP” on Bloomberg page “TFX.N <equity> AQR” (or its
equivalent successor if such page is not available) in respect of the period from scheduled open of
trading until the scheduled close of trading of the primary trading session on such Trading Day (or
if such volume-weighted average price is unavailable, the market value of one share of the Common
Stock on such Trading Day determined, using a volume-weighted average method, by a nationally
recognized independent investment banking firm retained for this purpose by the Company). The
“Daily VWAP” shall be determined without regard to after hours trading or any other trading outside
of the regular trading session trading hours.

     “Default” means any event that is, or with the passage of time or the giving of notice or both
would be, an Event of Default.

     “Defaulted Amounts” has the meaning specified in Section 5.06.

     “Depository” means initially The Depository Trust Company until a successor Depository shall
have become such pursuant to the applicable provisions of the Indenture, and thereafter
“Depository” shall mean such successor Depository.

     “Designated Senior Indebtedness” means:

     (1) any Indebtedness outstanding under the Credit Facilities;

5

 

     (2) any Indebtedness outstanding under the Existing Senior Notes; and

     (3) any other Senior Indebtedness the principal amount of which is $25.0 million or
more and that has been designated by the Company as “Designated Senior Indebtedness.”

     “Distributed Property” has the meaning specified in Section 4.04(c).

     “Dividend Threshold” means initially $0.34 and will be adjusted, in a manner inversely
proportional to adjustments to the Conversion Rate pursuant to Section 4.04; provided that no
adjustment will be made to the Dividend Threshold for any adjustment to the Conversion Rate under
Section 4.04(d).

     “Effective Date” has the meaning specified in Section 4.06(c).

     “Event of Default” has the meaning specified in Section 5.01.

     “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and
regulations promulgated thereunder.

     “Ex-Dividend Date” means the first date on which shares of the Common Stock trade on the
applicable exchange or in the applicable market, regular way, without the right to receive the
issuance, dividend or distribution in question.

     “Existing Note Purchase Agreement” means, with respect to any series or tranche of Existing
Senior Notes, the note purchase agreement among the Company, the guarantors thereto and the initial
holders of such Existing Senior Notes, as supplemented, amended, restated, extended, renewed,
replaced or otherwise modified from time to time prior to the date hereof.

     “Existing Senior Notes” (i) the Company’s (a) Series 2004-1 Tranche A Notes due 2011, (b)
Series 2004-1 Tranche B Notes due 2014 and (c) Series 2004-1 Tranche C Notes due 2016, each issued
pursuant to the Existing Note Purchase Agreement, dated July 8, 2004, as amended and (ii) the
Company’s (a) Series A Senior Notes due 2012, (b) Series B Senior Notes due 2014 and (c) Floating
Rate Series C Senior Notes due 2012, each issued pursuant to the Existing Note Purchase Agreement,
dated October 1, 2007.

     “Expiration Date” has the meaning specified in Section 4.04(e).

     “Form of Assignment and Transfer” means the “Form of Assignment and Transfer” attached as
Attachment 3 to the Form of Note attached hereto as Exhibit A.

     “Form of Fundamental Change Purchase Notice” means the “Form of Fundamental Change Purchase
Notice” attached as Attachment 2 to the Form of Note attached hereto as Exhibit A.

     “Form of Notice of Conversion” means the “Form of Notice of Conversion” attached as Attachment
1 to the Form of Note attached hereto as Exhibit A.

6

 

     “Fundamental Change” shall be deemed to have occurred at the time after the Notes are
originally issued if any of the following occurs:

     (1) a “person” or “group” within the meaning of Section 13(d) of the Exchange Act, other than
the Company, its Subsidiaries and its and their respective employee benefit plans, files a Schedule
TO or any schedule, form or report under the Exchange Act disclosing that such person or group has
become, or the Company acquires knowledge based upon a public announcement by such a person or
group, that such a person or group has become, the direct or indirect “beneficial owner,” as
defined in Rule 13d-3 under the Exchange Act, of the Company’s Common Equity representing more than
50% of the voting power of the Company’s Common Equity;

     (2) consummation of (i) any recapitalization, reclassification or change of the Common Stock
(other than changes resulting from a subdivision or combination) as a result of which the Common
Stock would be converted into, or exchanged for, stock, other securities, other property or assets
or (ii) any share exchange, consolidation or merger pursuant to which the Common Stock will be
converted into cash, securities or other property or assets, or any sale, conveyance, transfer,
lease or other disposition, in one transaction or a series of transactions, of all or substantially
all of the consolidated assets of the Company and its Subsidiaries, taken as a whole, to any person
other than the Company or one of its Subsidiaries; provided, however, that a transaction (1) as a
result of which the holders of all classes of the Company’s Common Equity immediately prior to such
transaction will own, directly or indirectly, more than 50% of all classes of Common Equity of the
continuing or surviving corporation or limited liability company (that is treated as a corporation
for U.S. federal income tax purposes) or transferee or a direct or indirect parent thereof
immediately after such transaction or (2) which is effected solely to change the Company’s
jurisdiction of incorporation into a jurisdiction within the U.S. and results in reclassification,
conversion or exchange of outstanding Common Stock solely into shares of common stock of the
surviving entity or a direct or indirect parent thereof, shall not be a Fundamental Change;
provided further, that, for the avoidance of doubt, the sale, conveyance, transfer, lease or other
disposition, in one transaction or a series of transactions, of all or substantially all of the
assets of the Company’s Commercial and/or Aerospace segments (as such terms are defined in the
Company’s condensed consolidated financial statements for the six months ended June 27, 2010) shall
not be a Fundamental Change;

     (3) the Company’s stockholders approve any plan or proposal for the liquidation or dissolution
of the Company; or

     (4) the Common Stock (or other common stock issuable upon conversion) ceases to be listed or
quoted on any of the New York Stock Exchange, the NASDAQ Global Select Market or the NASDAQ Global
Market (or any of their respective successors).

     A Fundamental Change as a result of clause (1), (2) or (4) above will not be deemed to have
occurred, however, in connection with any transaction or transactions described in clause (1) or
clause (2) pursuant to which at least 90% of the consideration (excluding cash payments for
fractional shares and cash payments made pursuant to dissenters appraisal rights and cash
dividends) received or to be received by holders of Common Stock in connection with such
transaction or transactions consists of shares of common stock or equivalent Common Equity

7

 

that are
listed or quoted on any of the New York Stock Exchange, the NASDAQ Global Select Market or the
NASDAQ Global Market (or any of their respective successors) or will be so listed or quoted when
issued or exchanged in connection with such transaction or transactions and as a result of this
transaction or transactions the notes become convertible based on such consideration pursuant to
the Section 4.07 and subject to Section 4.03.

     “Fundamental Change Company Notice” has the meaning specified in Section 3.01(b).

     “Fundamental Change Purchase Date” has the meaning specified in Section 3.01(a).

     “Fundamental Change Purchase Notice” has the meaning specified in Section 3.01(a)(1).

     “Fundamental Change Purchase Price” has the meaning specified in Section 3.01(a).

     “Fundamental Change Expiration Time” has the meaning specified in Section 3.01(a)(1).

     “GAAP” means generally accepted accounting principles set forth in the opinions and
pronouncements of the Accounting Principles Board of the American Institute of Certified Public
Accountants and statements and pronouncements of the Financial Accounting Standards Board or in
such other statements by such other entity as have been approved by a significant segment of the
accounting profession, which are in effect on the date of this Supplemental Indenture.

     “Global Note” means any Note that is a Global Security.

     “Guarantee” of or by any person means any obligation, contingent or otherwise, of the
guarantor guaranteeing or having the economic effect of guaranteeing any Indebtedness or other
obligation of any other person (the “primary obligor”) in any manner, whether directly or
indirectly, and including any obligation of the guarantor, direct or indirect:

     (1) to purchase or pay (or advance or supply funds for the purchase or payment of) such
Indebtedness or other obligation or to purchase (or to advance or supply funds for the purchase of)
any security for the payment thereof;

     (2) to purchase or lease property, securities or services for the purpose of assuring the
owner of such Indebtedness or other obligation of the payment thereof;

     (3) to maintain working capital, equity capital or any other financial statement condition or
liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness or
other obligation; or

     (4) as an account party in respect of any letter of credit or letter of guaranty issued to
support such Indebtedness or obligation;

     provided, that the term “Guarantee” will not include endorsements for collection or deposit in
the ordinary course of business. In any computation of the Indebtedness or other

8

 

liabilities of
the obligor under any Guarantee, the Indebtedness or other obligations that are the subject of such
Guarantee will be assumed to be direct obligations of such obligor.

     “Hedging Obligations” means, with respect to any specified person, the obligations
of such person under:

     (1) interest rate swap agreements (whether from fixed to floating or from floating to
fixed), interest rate cap agreements and interest rate collar agreements;

     (2) other agreements or arrangements designed to manage interest rates or interest rate
risk; and

     (3) commodity swap agreements, commodity cap agreements, commodity collar agreements,
foreign exchange contracts, currency swap agreements or any other agreements or arrangements
designed to protect such person against fluctuations in, or providing for the transfer or
mitigation of risks related to, currency exchange rates or commodity prices, in each case,
either generally or under specific contingencies.

     For the avoidance of doubt, no obligation of any specified person under any Permitted
Convertible Indebtedness Call Transaction will constitute a Hedging Obligation with respect to such
person.

     “Holder” means a person in whose name a Note is registered.

     “Indebtedness” of any person means, any indebtedness of such person (excluding accrued
expenses and commercial letters of credit, trade payables or similar obligations to a trade
creditor accrued in the ordinary course of business), whether or not contingent, without
duplication:

     (1) all Obligations of such person for borrowed money (including, without limitation,
any such obligations convertible into Capital Stock or other securities);

     (2) all Obligations of such person evidenced by bonds, debentures, notes or similar
instruments or letters of credit (or, without duplication, reimbursement agreements in
respect thereof);

     (3) all Obligations of such person in respect of the deferred and unpaid purchase price
of any property or services due more than six months after such property is acquired or such
services are completed, except any earn-out obligations until such obligation becomes a
liability on the balance sheet of such person in accordance with GAAP and if not paid after
becoming due and payable (excluding current accounts payable incurred in the ordinary course
of business);

     (4) all Indebtedness of others secured by (or for which the holder of such Indebtedness
has an existing right, contingent or otherwise, to be secured by) any Lien on property owned
or acquired by such person, whether or not the Indebtedness secured thereby has been
assumed;

9

 

     (5) all Guarantees by such person of Indebtedness of others;

     (6) all Capital Lease Obligations of such person;

     (7) all obligations, contingent or otherwise, of such person as an account party in
respect of letters of credit and letters of guaranty;

     (8) all obligations, contingent or otherwise, of such person in respect of bankers’
acceptances; and

     (9) representing any Hedging Obligations.

     For the avoidance of doubt, no indebtedness of any person under any Permitted Convertible
Indebtedness Call Transaction will constitute Indebtedness of such person. The Indebtedness of any
person shall include the Indebtedness of any other entity (including any partnership in which such
person is a general partner) to the extent such person is liable therefor as a result of such
person’s ownership interest in or other relationship with such entity, except to the extent the
terms of such Indebtedness provide that such person is not liable therefor.

     “Indenture” means the Original Indenture, as originally executed and as supplemented from time
to time by one or more indentures supplemental thereto, including this Supplemental Indenture,
entered into pursuant to the applicable provisions of the Indenture, including, for all purposes of
this instrument and any such supplemental indenture, the provisions of the Trust Indenture Act that
are deemed to be a part of and govern the Original Indenture, this Supplemental Indenture and any
other such supplemental indenture, respectively.

     “Initial Notes” has the meaning specified in Section 2.01.

     “Interest Payment Date” means, with respect to the payment of interest on the Notes, each
February 1 and August 1 of each year.

     “Issue Date” means, with respect to the Notes, August 9, 2010.

     “Last Reported Sale Price” of the Common Stock on any date means:

          (1) the closing sale price per share (or if no closing sale price is reported, the average of
the bid and ask prices or, if more than one in either case, the average of the average bid and the
average ask prices) on that date as reported in composite transactions for the principal U.S.
national or regional securities exchange on which the Common Stock is traded;

          (2) if the Common Stock is not listed for trading on a U.S. national or regional securities
exchange on the relevant date, the “Last Reported Sale Price” shall be the last quoted
bid price for the Common Stock in the over-the-counter market on the relevant date as reported
by Pink OTC Markets Inc. or a similar organization; or

          (3) if the Common Stock is not so quoted, the “Last Reported Sale Price” shall be as
determined by a nationally recognized independent investment banking firm selected

10

 

by the Company
for this purpose. The Last Reported Sale Price of the Common Stock will be determined without
reference to early hours, after hours or extended market trading.

     “Make-Whole Fundamental Change” means any transaction or event that constitutes a Fundamental
Change, determined after giving effect to any exceptions or exclusions to such definition,
including without limitation the first full paragraph immediately following clause (4) of the
definition thereof, but without regard to the first proviso in clause (2) of the definition
thereof.

     “Market Disruption Event” means:

     (1) for purposes of determining amounts due upon conversion pursuant to Section 4.03, (x) a
failure by the primary U.S. national or regional securities exchange or market on which the Common
Stock is listed or admitted to trading to open for trading during its regular trading session or
(y) the occurrence or existence prior to 1:00 p.m., New York City time, on any Scheduled Trading
Day for the Common Stock for more than a one half-hour period in the aggregate during regular
trading hours of any suspension or limitation imposed on trading (by reason of movements in price
exceeding limits permitted by the relevant securities exchange or otherwise) in the Common Stock or
in any options, contracts or future contracts relating to the Common Stock and

     (2) for all other purposes, if the Common Stock is listed for trading on the New York Stock
Exchange or another U.S. national or regional securities exchange, the occurrence or existence
during the one-half hour period ending on the scheduled close of trading on any Trading Day of any
material suspension or limitation imposed on trading (by reason of movements in price exceeding
limits permitted by the stock exchange or otherwise) in the Common Stock or in any options,
contracts or future contracts relating to the Common Stock.

     “Measurement Period” has the meaning specified in Section 4.01(b)(2).

     “Merger Common Stock” has the meaning specified in Section 4.07(c)(1).

     “Merger Event” has the meaning specified in Section 4.07(a).

     “Merger Valuation Percentage” has the meaning specified in Section 4.07(d)(1).

     “Merger Valuation Period” has the meaning specified in Section 4.07(d)(2).

     “Minimum Holder” has the meaning specified in Section 4.01(b)(2).

     “Nonpayment Default” has the meaning specified in Section 10.03(a)(2).

     “Note” or “Notes” has the meaning specified in the fourth paragraph of the recitals of this
Supplemental Indenture, and shall include any Additional Notes issued pursuant to Section 2.01.

11

 

     “Obligations” means any principal, interest, penalties, fees, premiums, make whole amounts,
indemnifications, reimbursements, damages and other costs, expenses and liabilities payable under
the documentation governing any Indebtedness.

     “open of business” means 9:00 a.m., New York City time.

     “Original Indenture” has the meaning specified in the first paragraph of this Supplemental
Indenture.

     “Outstanding” with respect to the Notes, has the meaning specified in Section 2.9 of the
Original Indenture with respect to Securities “outstanding,” as modified by Section 2.04 and
Section 3.04.

     “Paying Agent” has the meaning set forth in the Original Indenture, which shall initially be
the Trustee, and shall be the person authorized by the Company to pay the principal amount of,
interest on, or Fundamental Change Purchase Price of, any Notes on behalf of the Company.

     “Payment Blockage Notice” has the meaning specified in Section 10.03(a)(2).

     “Payment Default” has the meaning specified in Section 10.03(a)(1).

     “Permitted Convertible Indebtedness Call Transaction” means (i) any call or capped option (or
substantively equivalent derivative transaction) on Common Stock purchased by the Company or one of
its Subsidiaries in connection with the issuance of the Notes (a “Permitted Bond Hedge
Transaction”); and (ii) any call option, warrant or right to purchase (or substantively equivalent
derivative transaction) on Common Stock sold by the Company substantially concurrently with any
purchase of a related Permitted Bond Hedge Transaction (a “Permitted Warrant Transaction”).

     “Physical Notes” means certificated Notes that are not in global form and are registered in
the name of the Holder and issued in denominations of $1,000 principal amount and multiples
thereof.

     “Physical Settlement” has the meaning specified in Section 4.03(a).

     “Register” has the meaning specified in Section 2.4 of the Original Indenture with respect to
the register with respect to the Notes.

     “Regular Record Date” means, with respect to the payment of interest on the Notes, the January
15 (whether or not a Business Day) immediately preceding an Interest Payment Date on February 1 and
the July 15 (whether or not a Business Day) immediately preceding an Interest Payment Date on
August 1.

     “Reference Property” has the meaning specified in Section 4.07(a).

     “Representative” means the indenture trustee or other trustee, agent or representative for any
Senior Indebtedness; provided that, if no Representative has been appointed under the instrument
governing any series of Senior Indebtedness, any holder or group of holders of such

12

 

series of
Senior Indebtedness certifying that it holds a percentage of such series of Designated Senior
Indebtedness sufficient to cause the acceleration thereof will be deemed a Representative.

     “Scheduled Trading Day” means a day that is scheduled to be a Trading Day on the principal
U.S. national securities exchange or market on which the Common Stock is listed or admitted for
trading. If the Common Stock is not so listed or admitted for trading, “Scheduled Trading Day”
means a Business Day.

     “Senior Indebtedness” means:

     (1) all Indebtedness of the Company outstanding under the Credit Facilities, all
Existing Senior Notes, all Hedging Obligations, all Treasury Management Arrangements and all
Obligations with respect to any of the foregoing;

     (2) any other Indebtedness of the Company permitted to be incurred under the terms of
this Supplemental Indenture, unless the instrument under which such Indebtedness is incurred
expressly provides that it is on a parity with or subordinated in right of payment to the
Notes; and

     (3) all Obligations with respect to the items listed in the preceding clauses (1) and
(2).

Notwithstanding anything to the contrary in the foregoing, Senior Indebtedness will not include:

     (1) any liability for federal, state, local or other taxes owed or owing by the
Company;

     (2) any intercompany Indebtedness of the Company or any of its Subsidiaries to the
Company or any of its Affiliates;

     (3) any Indebtedness incurred for the purchase of goods or materials or for services
obtained in the ordinary course of business (other than with the proceeds of revolving
credit borrowings permitted hereby); or

     (4) the portion of any Indebtedness that is incurred in violation of this Supplemental
Indenture; provided that Indebtedness under Designated Senior Indebtedness will not cease to
be “Senior Indebtedness” by virtue of this clause (4) if it was advanced on the basis of an
Officers’ Certificate to the effect that it was permitted to be incurred under this
Supplemental Indenture.

     “Settlement Amount” has the meaning specified in Section 4.03(a)(2).

     “Settlement Election” has the meaning specified in Section 4.03(a)(1).

     “Settlement Election Notice” has the meaning specified in Section 4.03(a)(1).

     “Settlement Method” means, with respect to any conversion of Notes, Physical Settlement, Cash
Settlement or Combination Settlement, as elected by the Company.

13

 

     “Significant Subsidiary” means, with respect to any person, a Subsidiary of such person that
would constitute a “significant subsidiary” as such term is defined in Article 1, Rule 1-02 of
Regulation S-X, promulgated pursuant to the Securities Act, as in effect on the original date of
issuance of the Notes.

     “Specified Dollar Amount” means an amount of cash per $1,000 principal amount of converted
Note equal to $1,000; provided that, in the event of the delivery of any Settlement Election Notice
specifying a different Specified Dollar Amount pursuant to Section 4.03(a)(1), during the period
during which such Settlement Election Notice is effective, the Specified Dollar Amount shall be as
specified in such Settlement Election Notice.

     “Spin-Off” has the meaning specified in Section 4.04(c).

     “Stated Maturity” means, with respect to any Note and the payment of the principal amount
thereof, August 1, 2017.

     “Stock Price” has the meaning specified in Section 4.06(c).

     “Subsidiary” means, with respect to any specified person:

          (1) any corporation, association or other business entity of which more than 50% of the total
voting power of shares of Capital Stock entitled (without regard to the occurrence of any
contingency and after giving effect to any voting agreement or stockholders’ agreement that
effectively transfers voting power) to vote in the election of directors, managers or trustees of
the corporation, association or other business entity is at the time owned or controlled, directly
or indirectly, by that person or one or more of the other Subsidiaries of that person (or a
combination thereof); and

          (2) any partnership or limited liability company of which (a) more than 50% of the capital
accounts, distribution rights, total equity and voting interests or general and limited partnership
interests, as applicable, are owned or controlled, directly or indirectly, by such person or one or
more of the other Subsidiaries of that person or a combination thereof, whether in the form of
membership, general, special or limited partnership interests or otherwise, and (b) such person or
any Subsidiary of such person is a controlling general partner or otherwise controls such entity.

     “Successor Company” has the meaning specified in Section 8.01(a).

     “Supplemental Indenture” has the meaning specified in the first paragraph hereof.

     “Trading Day” means:

          (1) for purposes of determining amounts due upon conversion pursuant to Section 4.03 only, a
day on which (x) there is no Market Disruption Event (as defined in clause (1) of the definition
thereof) and (y) trading in the Common Stock generally occurs on the New
York Stock Exchange or, if the Common Stock is not then listed on the New York Stock Exchange,
on the principal other U.S. national or regional securities exchange on which the Common Stock is
then listed or, if the Common Stock is not then listed on a U.S. national or

14

 

regional securities
exchange, on the principal other market on which the Common Stock is then traded, except that if
the Common Stock (or other security for which a Daily VWAP must be determined) is not so listed or
traded, “Trading Day” means a Business Day; and

          (2) for all other purposes, a day on which trading in the Common Stock generally occurs on the
New York Stock Exchange or, if the Common Stock is not then listed on the New York Stock Exchange,
on the principal other U.S. national or regional securities exchange on which the Common Stock is
then listed or, if the Common Stock is not then listed on a U.S. national or regional securities
exchange, on the principal other market on which the Common Stock is then traded and there is no
Market Disruption Event (as defined in clause (2) of the definition thereof); provided that if the
Common Stock (or other security for which a closing sale price must be determined) is not so listed
or traded, “Trading Day” means a Business Day.

     “Trading Price” of the Notes on any date of determination means the average of the secondary
market bid quotations obtained by the Bid Solicitation Agent for $5.0 million principal amount of
the Notes at approximately 3:30 p.m., New York City time, on such determination date from three
independent nationally recognized securities dealers selected by the Company; provided that if
three such bids cannot reasonably be obtained by the Bid Solicitation Agent but two such bids are
obtained, then the average of the two bids shall be used, and if only one such bid can reasonably
be obtained by the Bid Solicitation Agent, that one bid shall be used. If the Bid Solicitation
Agent cannot reasonably obtain at least one bid for $5.0 million principal amount of the Notes from
a nationally recognized securities dealer, then the Trading Price per $1,000 principal amount of
Notes shall be deemed to be less than 98% of the product of the Last Reported Sale Price of the
Common Stock and the applicable Conversion Rate on such Trading Day.

     “Trading Price Condition” has the meaning specified in Section 4.01(b)(2).

     “Treasury Management Arrangement” means any agreement or other arrangement governing the
provision of treasury or cash management services, including deposit accounts, overdraft, credit or
debit card, funds transfer, automated clearinghouse, zero balance accounts, returned check
concentration, controlled disbursement, lockbox, account reconciliation and reporting and trade
finance services and other cash management services.

     “Trigger Event” has the meaning specified in Section 4.04(c).

     “Trustee” has the meaning set forth in the first paragraph of this Supplemental Indenture.

     “Underwriters” means Goldman, Sachs & Co.; Jefferies & Company Inc.; Morgan Stanley & Co.
Incorporated, Merrill Lynch, Pierce, Fenner & Smith Incorporated; and J.P. Morgan Securities Inc.

     “unit of Reference Property” has the meaning specified in Section 4.07(a).

     “U.S.” means the United States of America.

     “Valuation Period” has the meaning specified in Section 4.04(c).

15

 

     “Voting Stock” of any specified person as of any date means the Capital Stock of such person
that is at the time entitled to vote in the election of the Board of Directors of such person.

               Section 1.03 References to Interest. Any reference to interest on, or in respect of, any Note in the Indenture shall be deemed
to include Additional Interest if, in such context, Additional Interest is, was or would be payable
pursuant to Section 5.03. Any express mention of the payment of Additional Interest in any
provision hereof shall not be construed as excluding Additional Interest in those provisions hereof
where such express mention is not made.

ARTICLE 2.

THE SECURITIES

               Section 2.01 Title and Terms; Payments. There is hereby established a Series of Securities designated the “3.875% Convertible
Senior Subordinated Notes due 2017” initially limited in aggregate principal amount to
$400,000,000, which amount shall be as set forth in a Company Order for the authentication and
delivery of Notes pursuant to Section 2.3 of the Original Indenture.

     The principal amount of Notes then Outstanding shall be payable at the Stated Maturity.
Interest on the Notes shall accrue at a rate of 3.875% per annum, from the Issue Date or from the
most recent date on which interest has been paid or duly provided for, until the principal thereof
is paid or made available for payment. Interest shall be payable semi-annually in arrears on each
Interest Payment Date, beginning on February 1, 2011, to the person in whose name a Note is
registered on the Register at the close of business on the Regular Record Date immediately
preceding the applicable Interest Payment Date. Interest will be computed on the basis of a
360-day year composed of twelve 30-day months. The Notes will not have the benefit of Article XIII
of the Original Indenture.

     The Company may, at its election and without notice to or the consent of the Holders of the
Notes, hereafter issue additional notes (“Additional Notes”) under the Indenture with the same
terms and with the same CUSIP numbers as the Notes issued on the date of this Supplemental
Indenture (the “Initial Notes”) in an unlimited aggregate principal amount. The Notes and such
Additional Notes, if any, will be treated as a single class for all purposes of the Indenture,
including waivers, amendments and offers to purchase; provided that, if any such Additional Notes
subsequently issued are not fungible for U.S. federal income tax purposes or securities law
purposes with any Notes previously issued, such Additional Notes shall trade separately from such
previously issued Notes under a separate CUSIP number but shall otherwise be treated as a single
class with all other Notes issued under the Indenture.

     The Form of Note shall be substantially as set forth in Exhibit A and the Form of Notice of
Conversion, the Form of Fundamental Change Purchase Notice and the Form of Assignment
and Transfer shall be substantially as set forth in Attachments 1, 2 and 3, respectively, to
Exhibit A, each of which is incorporated into and shall be deemed a part of this Supplemental
Indenture, and in each case with such appropriate insertions, omissions, substitutions and other
variations as are required or permitted by the Indenture, and may have such letters, numbers or
other marks of identification and such legends or endorsements placed thereon as may be required to
comply with the rules of any securities exchange or as may, consistently herewith, be determined to
be

16

 

necessary or appropriate by the Officers of the Company executing such Notes, as evidenced by
their execution of the Notes.

     The Company shall pay the principal of and interest on any Global Note in immediately
available funds to the Depository or its nominee, as the case may be, as the registered Holder of
such Global Note. The Company shall pay the principal of and interest on any Physical Notes at the
office or agency designated by the Company for that purpose, unless a Holder timely requests to
have such amounts paid by wire transfer in accordance with the final three sentences of this
paragraph, in which case the Company shall instead pay such principal of and interest on any
Physical Notes by wire transfer in accordance with the transfer instructions provided in such
request. The Company has initially designated the Trustee as its Paying Agent and its Registrar in
respect of the Notes and its agency in New York City as a place where Notes may be presented for
payment or for registration of transfer. The Company may, however, change the Paying Agent or the
Registrar for the Notes without prior notice to the Holders thereof, and the Company or one of its
wholly owned Subsidiaries may act as the Paying Agent or the Registrar for the Notes. Payments on
any Physical Notes having a principal amount of at least $10,000,000 shall be payable, if the
Holder of such Physical Notes so requests in accordance with the two immediately succeeding
sentences, by wire transfer of immediately available funds to an account specified by the Holder at
a bank in New York City, New York. To request payment by wire transfer, the Holder must give
appropriate transfer instructions to the Trustee or other Paying Agent (if not the Trustee) at
least 15 Business Days before the requested wire payment is due and, in the case of any interest
payments, the instructions must be given by the person who is shown on the Trustee’s records as the
Holder of the Physical Note on the applicable Regular Record Date. All applications for payment by
wire transfer shall remain in effect unless and until new instructions are given in the manner
described in the immediately preceding sentence.

     A Holder may transfer or exchange Notes at the office of the Registrar in accordance with
Section 2.7 of the Original Indenture. The Company is not required to transfer or exchange any
Note surrendered for conversion pursuant to Section 4.01(b).

               Section 2.02
Book-Entry Provisions for Global Notes. (a) The Notes initially shall be issued in the form of one or more Global Notes without
interest coupons (i) registered in the name of Cede & Co., as nominee of the Depository and
(ii) delivered to the Trustee as custodian for the Depository.

     Members of, or participants in, the Depository (“Agent Members”) shall have no rights under
this Supplemental Indenture or the Original Indenture with respect to any Global Note held on their
behalf by the Depository, or the Trustee as its custodian, or under the Global Note, and Cede &
Co., or such other person designated by the Depository as its nominee, may be treated by
the Company, the Trustee and any agent of the Company or the Trustee as the absolute owner of
the Global Note for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall
prevent the Company, the Trustee or any agent of the Company or the Trustee from giving effect to
any written certification, proxy or other authorization furnished by the Depository or impair, as
between the Depository and its Agent Members, the operation of customary practices governing the
exercise of the rights of any Holder.

17

 

     (b) Transfers of Global Notes shall be limited to transfers in whole, but not in part, to
the Depository, its successors or their respective nominees. Notwithstanding anything to the
contrary in Section 2.7 of the Original Indenture, interests of beneficial owners in a Global
Note may be transferred or exchanged, in whole or in part, for Physical Notes, only if:

          (1) the Depository notifies the Company at any time that the Depository is unwilling or unable
to continue as Depository for the Global Notes and a successor Depository is not appointed within
60 days;

          (2) the Depository ceases to be registered as a clearing agency under the Exchange Act and a
successor Depository is not appointed within 60 days; or

          (3) an Event of Default with respect to the Notes has occurred and is continuing and such
beneficial owner requests that its Notes be issued as Physical Notes,

in each case in accordance with the rules and procedures of the Depository. Other than as set
forth in this Section 2.02(b), the Notes shall remain in global form as Global Notes.

     (c) In connection with any transfer or exchange of a portion of the beneficial interest
in the Global Note to beneficial owners pursuant to Section 2.7 of the Original Indenture, as
modified by this Section 2.02, the Registrar shall (if one or more Physical Notes are to be
issued) reflect on its books and records the date and a decrease in the principal amount of
the Global Note in an amount equal to the principal amount of the beneficial interest in the
Global Note to be transferred, and the Company shall execute, and the Trustee shall
authenticate and deliver, one or more Physical Notes of like tenor and amount in accordance
with Section 2.7 of the Original Indenture, as modified by this Section 2.02.

     (d) In connection with the transfer of the entire Global Note to beneficial owners
pursuant to Section 2.7 of the Original Indenture, as modified by this Section 2.02, the
Global Note shall be deemed to be surrendered to the Trustee for cancellation, and the Company
shall execute, and the Trustee shall authenticate and deliver, to each beneficial owner
identified by the Depository in exchange for its beneficial interest in the Global Note, an
equal aggregate principal amount of Physical Notes of authorized denominations and the same
tenor.

     (e) The Holder of Global Notes may grant proxies and otherwise authorize any person,
including Agent Members and persons that may hold interests through Agent Members, to take any
action that a Holder is entitled to take under this Supplemental Indenture, Original Indenture
or the Notes.

               Section 2.03 Reporting Requirement. For purposes of Section 4.4 of the Original Indenture, (i) Clause (i) of Section 4.4(a)
shall not apply and the applicable date set forth in clause (ii) of such Section 4.4(a) shall give
effect to any grace period provided by Rule 12b-25 under the Exchange Act and (ii) documents filed
by the Company with the Commission via the Commission’s EDGAR system shall be deemed to be filed
with the Trustee as of the time

18

 

such documents are filed via the Commission’s EDGAR system. For
the Trustee’s administrative convenience, the Company shall notify the Trustee by email of such
filing.

               Section 2.04 Repurchase and Cancellation. To the extent permitted by law, the Company may at any time and from time to time
repurchase Notes in open market purchases or by tender at any price or in negotiated transactions
without giving prior notice to Holders. The Company shall surrender any Notes repurchased by the
Company to the Trustee for cancellation in accordance with Section 2.12 of the Original Indenture
and any such Notes repurchased by the Company shall be deemed to be no longer Outstanding. Any
Notes surrendered for cancellation by the Company shall not be reissued or resold.

ARTICLE 3.

FUNDAMENTAL CHANGES AND PURCHASES THEREUPON

               Section 3.01 Purchase at Option of Holders Upon a Fundamental Change. (a) If a Fundamental Change occurs at any time prior to the Stated Maturity, then
each Holder of Notes shall have the right, at such Holder’s option, to require the Company to
purchase for cash any or all of such Holder’s Notes, or any portion of the principal amount
thereof, that is equal to $1,000 or an integral multiple of $1,000, on a date (the
“Fundamental Change Purchase Date”) specified by the Company that is not less than 20 calendar
days or more than 35 calendar days following the date of the Fundamental Change Company
Notice, at a purchase price equal to 100% of the principal amount thereof, plus accrued and
unpaid interest thereon, if any, to, but excluding, the Fundamental Change Purchase Date (the
“Fundamental Change Purchase Price”); provided, however, that if the Fundamental Change
Purchase Date is after a Regular Record Date and on or prior to the Interest Payment Date to
which such Regular Record Date relates, the Company shall instead pay the full amount of
accrued and unpaid interest on the Interest Payment Date to the Holders of record as of the
preceding Regular Record Date.

     Purchases of Notes under this Section 3.01 shall be made, at the option of the Holder thereof,
upon:

          (1) delivery to the Paying Agent by a Holder of a duly completed notice (the “Fundamental
Change Purchase Notice”) in the form set forth in Attachment 2 to the Form of Note attached hereto
as Exhibit A (if the Notes are Physical Notes) or in compliance with the Depository’s procedures
for tendering interests in Global Notes (if the Notes are Global Notes)
in each case before the close of business on the Business Day immediately preceding the
Fundamental Change Purchase Date (the “Fundamental Change Expiration Time”); and

          (2) delivery of the Notes, in the case of Physical Notes, to the Paying Agent appointed by the
Company (together with all necessary endorsements for transfer), or book-entry transfer of the
Notes, in compliance with the procedures of the Depository, such delivery or transfer being a
condition to receipt by the Holder of the Fundamental Change Purchase Price therefor.

     The Fundamental Change Purchase Notice in respect of any Notes to be purchased shall state:

19

 

          (1) if such Notes are Physical Notes, the certificate numbers of such Notes;

          (2) the portion of the principal amount of such Notes, which must be $1,000 or an integral
multiple thereof; and

          (3) that such Notes are to be purchased by the Company pursuant to the applicable provisions
of the Notes and this Supplemental Indenture;

provided, however, that if such Notes are Global Notes, the Fundamental Change Purchase Notice must
also comply with appropriate procedures of the Depository; provided, further that that if Physical
Notes have not been issued, the Fundamental Change Purchase Notice must comply with appropriate
procedures of the Depository.

     Notwithstanding anything herein to the contrary, any Holder delivering to the Paying Agent the
Fundamental Change Purchase Notice contemplated by this Section 3.01 shall have the right to
withdraw, in whole or in part, such Fundamental Change Purchase Notice at any time prior to the
Fundamental Change Expiration Time by delivery of a written notice of withdrawal to the Paying
Agent in accordance with Section 3.03.

     The Paying Agent shall promptly notify the Company of the receipt by it of any Fundamental
Change Purchase Notice or written notice of withdrawal thereof.

     (b) On or before the 20th calendar day after the occurrence of a Fundamental Change, the
Company shall provide to all Holders of the Notes, the Trustee and the Paying Agent (in the
case of any Paying Agent other than the Trustee) a notice (the “Fundamental Change Company
Notice”) of the occurrence of such Fundamental Change and of the purchase right at the option
of the Holders arising as a result thereof. Such notice shall be sent by first class mail or,
in the case of any Global Notes, in accordance with the procedures of the Depository for
providing notices. Simultaneously with providing such Fundamental Change Company Notice, the
Company shall make a press release and publish such information on the Company’s website or
through such other public medium as the Company may use at such time.

     Each Fundamental Change Company Notice shall specify:

          (1) the events causing the Fundamental Change;

          (2) the date of the Fundamental Change;

          (3) the last date on which a Holder of Notes may exercise the purchase right pursuant to this
Article 3;

          (4) the Fundamental Change Purchase Price;

          (5) the Fundamental Change Purchase Date;

          (6) the name and address of the Paying Agent and the Conversion Agent, if applicable;

20

 

          (7) the applicable Conversion Rate and any adjustments to the applicable Conversion Rate;

          (8) that the Notes with respect to which a Fundamental Change Purchase Notice has been
delivered by a Holder may be converted only if the Holder withdraws the Fundamental Change Purchase
Notice in accordance with this Supplemental Indenture;

          (9) that the Holder must exercise the purchase right prior to the Fundamental Change
Expiration Time;

          (10) that the Holder shall have the right to withdraw any Notes surrendered for purchase prior
to the Fundamental Change Expiration Time; and

          (11) the procedures that Holders must follow to require the Company to purchase their Notes.

     No failure of the Company to give the foregoing notices and no defect therein shall limit the
purchase rights of the Holders of Notes or affect the validity of the proceedings for the purchase
of the Notes pursuant to this Section 3.01.

     (c) Notwithstanding the foregoing, there shall be no purchase of any Notes pursuant to
this Section 3.01 if the principal amount of the Notes has been accelerated, and such
acceleration has not been rescinded, on or prior to the Fundamental Change Purchase Date
(except in the case of an acceleration resulting from a Default by the Company in the payment
of the Fundamental Change Purchase Price with respect to such Notes). The Paying Agent will
promptly return to the respective Holders thereof any Physical Notes held by it during the
acceleration of the Notes (except in the case of an acceleration resulting from a Default by
the Company in the payment of the Fundamental Change Purchase Price with respect to such
Notes) and shall deem to be cancelled any instructions for book-entry transfer of the Notes in
compliance with the procedures of the Depository, in which case, upon such return or
cancellation, as the case may be, the Fundamental Change Purchase Notice with respect thereto
shall be deemed to have been withdrawn.

               Section 3.02 Effect of Fundamental Change Purchase Notice. Upon receipt by the Paying Agent of a Fundamental Change Purchase Notice specified in
Section 3.01, the Holder of the Note in respect of which such Fundamental Change Purchase Notice
was given shall (unless such Fundamental Change Purchase Notice is withdrawn in accordance with
Section 3.03) thereafter be entitled to receive solely the Fundamental Change Purchase Price in
cash with respect to such Note. Such Fundamental Change Purchase Price shall be paid to such
Holder, subject to receipt of funds by the Paying Agent, on the later of (x) the applicable
Fundamental Change Purchase Date (provided the conditions in Section 3.01 have been satisfied) and
(y) the time of delivery or book-entry transfer of such Note to the Paying Agent by the Holder
thereof in the manner required by Section 3.01.

               Section 3.03 Withdrawal of Fundamental Change Purchase Notice. A Fundamental Change Purchase Notice may be withdrawn (in whole or in part) by means of a
written notice of withdrawal delivered to the Paying Agent in accordance with the Fundamental

21

 

Change Company Notice at any time prior to the Fundamental Change Expiration Time, specifying:

          (1) the principal amount of the Notes with respect to which such notice of withdrawal is being
submitted;

          (2) if Physical Notes have been issued, the certificate numbers of the withdrawn Notes; and

          (3) the principal amount, if any, of such Notes that remains subject to the original
Fundamental Change Purchase Notice, which portion must be in principal amounts of $1,000 or an
integral multiple of $1,000;

provided, however, that if Physical Notes have not been issued, the notice must comply with
appropriate procedures of the Depository.

     The Paying Agent will promptly return to the respective Holders thereof any Physical Notes
with respect to which a Fundamental Change Purchase Notice has been withdrawn in compliance with
the provisions of this Section 3.03.

               Section 3.04 Deposit of Fundamental Change Purchase Price. Prior to 11:00 a.m., New York City time on the Fundamental Change Purchase Date, the
Company shall deposit with the Paying Agent (or, if the Company or a Subsidiary or an Affiliate of
either of them is acting as the Paying Agent, shall segregate and hold in trust as provided herein)
an amount of money (in immediately available funds if deposited on such Business Day) sufficient to
pay the Fundamental Change Purchase Price of all the Notes or portions thereof that are to be
purchased as of the Fundamental Change Purchase Date. If the Paying Agent holds cash sufficient to
pay the Fundamental Change Purchase Price of the Notes for which a Fundamental Change Purchase
Notice has been tendered and not withdrawn in accordance with this Supplemental Indenture on the
Fundamental Change Purchase Date, then as of such Fundamental Change Purchase Date, (a) such Notes
will cease to be Outstanding and interest will cease to accrue thereon (whether or not book-entry
transfer of such Notes is made or such Notes have been delivered to the Paying Agent) and (b) all
other rights of the Holders in
respect thereof will terminate (other than the right to receive the Fundamental Change
Purchase Price upon delivery or book-entry transfer of such Notes).

               Section 3.05 Notes Purchased in Whole or in Part. Any Note that is to be purchased, whether in whole or in part, shall be surrendered at the
office of the Paying Agent (with, if the Company or the Trustee so requires in the case of Physical
Notes, due endorsement by, or a written instrument of transfer in form satisfactory to the Company
and the Trustee duly executed by, the Holder thereof or such Holder’s attorney duly authorized in
writing) and the Company shall execute and the Trustee shall authenticate and deliver to the Holder
of such Note, without service charge, a new Note or Notes, of any authorized denomination as
requested by such Holder in aggregate principal amount equal to, and in exchange for, the portion
of the principal amount of the Note so surrendered that is not purchased.

               Section 3.06 Covenant to Comply With Applicable Laws Upon Purchase of Notes. In connection with any offer to purchase Notes under Section 3.01, the Company shall,

22

 

in
each case if required, (i) comply with Rule 13e-4, Rule 14e-1 and any other tender offer rules
under the Exchange Act that may then be applicable, (ii) file a Schedule TO or any other required
schedule under the Exchange Act and (iii) otherwise comply with all federal and state securities
laws, in each case, so as to permit the rights and obligations under Section 3.01 to be exercised
in the time and in the manner specified in Section 3.01.

               Section 3.07 Repayment to the Company. To the extent that the aggregate amount of cash deposited by the Company pursuant to
Section 3.04 exceeds the aggregate Fundamental Change Purchase Price of the Notes or portions
thereof that the Company is obligated to purchase as of the Fundamental Change Purchase Date, then,
following the Fundamental Change Purchase Date, the Paying Agent shall promptly return any such
excess to the Company.

ARTICLE 4.

CONVERSION

               Section 4.01 Right to Convert. (a) Subject to and upon compliance with the provisions of this Article 4, each
Holder of Notes shall have the right, at such Holder’s option, to convert the principal amount
of any such Notes, or any portion of such principal amount equal to $1,000 or an integral
multiple thereof, at the Conversion Rate then in effect (subject to the settlement provisions
set forth in Section 4.03, the “Conversion Obligation”) (x) prior to the close of business on
the Business Day immediately preceding May 1, 2017, only upon satisfaction of one or more of
the conditions described in Section 4.01(b) and (y) on or after May 1, 2017, at any time prior
to the close of business on the second Scheduled Trading Day immediately preceding the Stated
Maturity.

     (b) (1) The Notes may be surrendered for conversion during any fiscal quarter (and only
during such fiscal quarter) commencing after September 26, 2010, if the Last Reported Sale
Price of the Common Stock for at least 20 Trading Days (whether or not consecutive) during the
period of 30 consecutive Trading Days ending on the last Trading Day of the immediately
preceding fiscal quarter is greater than 130% of the applicable Conversion Price on each
applicable Trading Day. The Company shall determine at the beginning of each fiscal quarter
commencing after September 26, 2010 whether the Notes may be surrendered for conversion in
accordance with this clause (1) and shall notify the Company and the Trustee (in the case of a
Conversion Agent other than the Trustee) if the Notes become convertible in accordance with
this clause (1).

     (2) The Notes may be surrendered for conversion during the five Business Day period after any
five consecutive Trading Day period (the “Measurement Period”) in which the Trading Price per
$1,000 principal amount of Notes, as determined following a request by a Holder of at least $1.0
million aggregate principal amount of Notes (a “Minimum Holder”) in accordance with the procedures
set forth in this clause (2), for each Trading Day of such Measurement Period was less than 98% of
the product of the Last Reported Sale Price of the Common Stock on such Trading Day and the
applicable Conversion Rate on such Trading Day (the “Trading Price Condition”). The Trading Prices
shall be determined by the Bid Solicitation Agent pursuant to this clause (2) and the definition of
“Trading Price” set forth in Section 1.02. The Company shall provide written notice to the Bid
Solicitation Agent (if other

23

 

than the Company) of the three independent nationally recognized
securities dealers selected by the Company in accordance with the definition of Trading Price,
along with appropriate contact information for each. The Bid Solicitation Agent (if other than the
Company) shall have no obligation to determine the Trading Price of the Notes in accordance with
this clause (2) unless requested by the Company, and the Company shall have no obligation to make
such request unless a Minimum Holder provides the Company with reasonable evidence that the
Trading Price per $1,000 principal amount of the Notes would be less than 98% of the product of the
Last Reported Sale Price of the Common Stock and the applicable Conversion Rate, at which time the
Company shall instruct the Bid Solicitation Agent to determine (or, if the Company is then acting
as Bid Solicitation Agent, the Company shall determine) the Trading Price of the Notes beginning on
the next Trading Day following the receipt of such evidence and on each successive Trading Day
until the Trading Price per $1,000 principal amount of Notes is greater than or equal to 98% of the
product of the Last Reported Sale Price of the Common Stock and the applicable Conversion Rate. If
the Company does not so instruct the Bid Solicitation Agent to obtain (or, if the Company is then
acting as Bid Solicitation Agent, the Company does not obtain) bids when required, then the Trading
Price per $1,000 principal amount of Notes shall be deemed to be less than 98% of the product of
the Last Reported Sale Price of the Common Stock and the applicable Conversion Rate on each day the
Company fails to do so. If the Trading Price Condition has been met, the Company shall so notify
the Holders, the Trustee and the Conversion Agent (if other than the Trustee). If, at any time
after the Trading Price Condition has been met, the Trading Price per $1,000 principal amount of
Notes is greater than or equal to 98% of the product of the Last Reported Sale Price of the Common
Stock on such Trading Day and the applicable Conversion Rate, the Company shall so notify the
Holders of the Notes, the Trustee and the Conversion Agent (if other than the Trustee).

     (3) Prior to the close of business on the Business Day immediately preceding May 1, 2017, if
the Company elects to:

     (a) issue to all or substantially all holders of the Common Stock rights, options or
warrants entitling them, for a period of not more than 45 calendar days after the date of
such issuance to subscribe for or purchase shares of the Common Stock, at a price per share
less than the average of the Last Reported Sale Prices of the Common Stock for the 10
consecutive Trading Day period ending on the Trading Day immediately preceding the date of
announcement of such issuance; or

     (b) distribute to all or substantially all holders of the Common Stock the Company’s
assets, debt securities or rights to purchase securities of the Company, which distribution
has a per share value, as reasonably determined by the Board of Directors, exceeding 10% of
the Last Reported Sale Price of the Common Stock on, and including, the Trading Day
immediately preceding the date of announcement for such distribution,

then, in each case, the Company shall notify the Holders of the Notes at least 85 Scheduled Trading
Days prior to the Ex-Dividend Date for such issuance or distribution. The Company shall notify
Holders of any such issuance or distribution with Ex-Dividend Date on or after May 1, 2017 and on
or prior to August 1, 2017, at least 85 Scheduled Trading Days prior to such Ex-Dividend Date.
Once the Company has given such notice, a Holder may surrender all or a

24

 

portion of its Notes for
conversion at any time until the earlier of (x) the close of business on the Business Day
immediately preceding such Ex-Dividend Date and (y) the Company’s announcement that such issuance
or distribution will not take place. A Holder may not convert any Notes based on this Section
4.01(b)(3) if such Holder of the Notes participates, at the same time and upon the same terms as
holders of Common Stock and as a result of holding the Notes, in any of the transactions described
in this Section 4.01(b)(3) without having to convert its Notes as if it held a number of shares of
Common Stock equal to the applicable Conversion Rate multiplied by the principal amount (expressed
in thousands) of Notes held by such Holder.

     (4) Prior to the close of business on the Business Day immediately preceding May 1, 2017, if:

     (a) a Fundamental Change occurs;

     (b) a Make-Whole Fundamental Change occurs; or

     (c) the Company is a party to (i) a consolidation, merger or binding share exchange
pursuant to which the Common Stock would be converted into cash, securities or other assets
or (ii) a sale, conveyance, transfer or lease of all or substantially all of its assets, in
each case that does not constitute a Fundamental Change;

a Holder may surrender all or a portion of its Notes for conversion at any time from or after the
effective date of the transaction until 35 Trading Days immediately following such effective date,
or if such transaction also constitutes a Fundamental Change, until the related Fundamental Change
Purchase Date. The Company shall notify Holders and the Trustee as promptly as
practicable following the date on which the Company publicly announces such transaction
but in no event later than five Business Days after the effective date of such transaction.

               Section 4.02 Conversion Procedures. (a) Each Note shall be convertible at the office of the Conversion Agent and, if
applicable, in accordance with the procedures of the Depository.

     (b) In order to exercise the conversion privilege with respect to a beneficial interest
in a Global Note, the Holder must complete the appropriate instruction form for conversion
pursuant to the Depository’s book-entry conversion program, furnish appropriate endorsements
and transfer documents if required by the Company or the Conversion Agent, and pay the funds,
if any, required by Section 4.03(c) and any taxes or duties if required pursuant to Section
4.08, and the Conversion Agent must be informed of the conversion in accordance with the
customary practice of the Depository. In order to exercise the conversion privilege with
respect to any Physical Notes, the Holder of any such Notes to be converted, in whole or in
part, shall:

          (1) complete and manually sign a conversion notice in the form set forth in the Form of Notice
of Conversion (the “Conversion Notice”) or a facsimile of the Conversion Notice;

          (2) deliver the Conversion Notice, which is irrevocable, and the Note to the Conversion Agent;

25

 

          (3) if required, furnish appropriate endorsements and transfer documents,

          (4) if required, make any payment required under Section 4.03(c); and

          (5) if required, pay all transfer or similar taxes as set forth in Section 4.08.

The date on which the Holder satisfies all of the applicable requirements set forth above shall be
the “Conversion Date” with respect to such Notes surrendered for conversion. The Conversion Agent
will, as promptly as possible, and in any event within one Business Day of the receipt thereof,
provide the Company with notice of any conversion by a Holder of the Notes.

     (c) Each Conversion Notice shall state the name or names (with address or addresses) in
which any certificate or certificates for shares of Common Stock which shall be issuable on
such conversion shall be issued. All such Notes surrendered for
conversion shall, unless the shares of Common Stock issuable on conversion are to be issued in the same name as the
registration of such Notes, be duly endorsed by, or be accompanied by instruments of transfer
in form satisfactory to the Company duly executed by, the Holder or its duly authorized
attorney.

     (d) In case any Notes of a denomination greater than $1,000 shall be surrendered for
partial conversion, the Company shall execute and the Trustee shall authenticate and deliver
to the Holder of the Notes so surrendered, without charge, new Notes in authorized
denominations in an aggregate principal amount equal to the unconverted portion of the
surrendered Notes.

     Each conversion shall be deemed to have been effected as to any such Notes (or portion
thereof) surrendered for conversion on the relevant Conversion Date; provided, however, that the
person in whose name the certificate for any shares of Common Stock delivered upon conversion is
registered shall be treated as a stockholder of record as of the close of business on the relevant
Conversion Date (if the Company elects to satisfy the related Conversion Obligation by Physical
Settlement) or the last Trading Day of the applicable Cash Settlement Averaging Period, subject to
Section 4.04(h) (if the Company elects to satisfy the related Conversion Obligation by Combination
Settlement), as the case may be. Upon the Conversion Date of Notes surrendered for conversion,
such person shall no longer be a Holder with respect to such Notes.

     (e) Upon the conversion of a beneficial interest in Global Notes, the Conversion Agent
shall make a notation in its records as to the reduction in the principal amount represented
thereby. The Company shall notify the Trustee in writing of any conversions of Notes effected
through any Conversion Agent other than the Trustee.

     (f) Notwithstanding the foregoing, a Note in respect of which a Holder has delivered a
Fundamental Change Purchase Notice exercising such Holder’s right to require the Company to
purchase such Note may be converted only if such Fundamental Change Purchase Notice is
withdrawn in accordance with Section 3.03 prior to the relevant Fundamental Change Purchase
Expiration Time, except to the extent that a portion of such Holder’s Note is not subject to
such Fundamental Change Purchase Notice.

26

 

               Section 4.03
Settlement Upon Conversion. (a) Subject to this Section 4.03 and Section 4.06(b), upon conversion of any Note, the
Company may elect to deliver to Holders in full satisfaction of its Conversion Obligation in
respect of each $1,000 principal amount of Notes being converted:
cash (“Cash Settlement”), shares of Common Stock, together with cash, if applicable, in lieu of any fractional share of
Common Stock in accordance with Section 4.03(d) (“Physical Settlement”) or a combination of
cash and shares of Common Stock, together with cash, if applicable, in lieu of any fractional
share of Common Stock in accordance with Section 4.03(d) (“Combination Settlement”).

          (1) The Company shall from time to time make an election with respect to the Settlement Method
it chooses to satisfy its Conversion Obligation (a “Settlement Election”). Each Settlement Election
shall be effective until the Company provides a notice of a different Settlement Election (each
such notice, a “Settlement Election Notice”), and such different Settlement Election becomes
effective. The Company may not make a different Settlement Election after the 165th
Scheduled Trading Day preceding the Stated Maturity. As of the date of this Supplemental Indenture,
the Company has made a Settlement Election of Combination Settlement with a Specified Dollar Amount
equal to $1,000. If the Company makes a different Settlement Election, the Company shall provide
to all Holders, the Trustee and the Conversion Agent a Settlement Election Notice with respect to
each Settlement Election specifying the newly chosen Settlement Method, the effective date of such
Settlement Election (which cannot
be earlier than the third Scheduled Trading Day following the delivery of such Settlement
Election Notice) and in the case of Combination Settlement, the Specified Dollar Amount. If the
Company makes a Settlement Election specifying Combination Settlement in respect of its Conversion
Obligation but does not specify a Specified Dollar Amount in the notice of such Settlement
Election, the Specified Dollar Amount shall be deemed to be equal to $1,000. Simultaneously with
providing such Settlement Election Notice, the Company shall issue a press release containing the
relevant information and make such information available on its website.

     In addition, the Company may at any time irrevocably elect Combination Settlement with a
Specified Dollar Amount of $1,000; provided, however, that after the 165th Scheduled
Trading Day preceding the Stated Maturity, in no event may the Company make such irrevocable
election if such election would result in a different Settlement Method. The Company may make such
irrevocable election in its sole discretion without any consent of the Holders. If the Company
chooses to make this irrevocable election, the Company shall provided notice to all Holders, the
Trustee and the Conversion Agent. Simultaneously with providing such notice, the Company shall
issue a press release containing the relevant information and make this information available on
its website. Following such irrevocable election, the Company will not have the right to make a
different Settlement Election.

          (2) The cash, shares of Common Stock or combination of cash and shares of Common Stock in
respect of any conversion of Notes (the “Settlement Amount”) shall be computed as follows:

     (a) if the Company elects to satisfy its Conversion Obligation in respect of such
conversion by Physical Settlement, the Company shall deliver to the converting Holder a
number of shares of Common Stock per $1,000 principal amount of Notes being converted equal
to the applicable Conversion Rate together with cash, if

27

 

applicable, in lieu of fractional
share of Common Stock in accordance with Section 4.03(d);

     (b) if the Company elects to satisfy its Conversion Obligation in respect of such
conversion by Cash Settlement, the Company shall pay to the converting Holder in respect of
each $1,000 principal amount of Notes being converted cash in an amount equal to the sum of
the Daily Conversion Values for each of the 80 consecutive Trading Days during the applicable
Cash Settlement Averaging Period; and

     (c) if the Company elects to satisfy its Conversion Obligation in respect of such
conversion by Combination Settlement, the Company shall pay and deliver, as the case may be,
for each $1,000 principal amount of Notes being converted, an amount of cash and shares of
Common Stock equal to the sum of the Daily Settlement Amounts for each of the 80 consecutive
Trading Days during the applicable Cash Settlement Averaging Period, together with cash, if
applicable, in lieu of any fractional share of Common Stock in accordance with Section
4.03(d).

          (3) The Company shall pay or deliver, as the case may be, the consideration due in respect of
its Conversion Obligation (i) on the third Business Day immediately following the applicable
Conversion Date, if the Company elects to satisfy its Conversion Obligation in
respect of such conversion by Physical Settlement; provided that for all such conversions
occurring on or after the Regular Record Date immediately preceding the Stated Maturity, the
Company shall deliver the shares of Common Stock on the Stated Maturity; and (ii) on the third
Business Day immediately following the last Trading Day of the applicable Cash Settlement Averaging
Period, if the Company elects to satisfy its Conversion Obligation in respect of such conversion by
Cash Settlement or Combination Settlement.

     (b) The Daily Settlement Amounts (if applicable) and the Daily Conversion Values (if
applicable) shall be determined by the Company promptly following the last day of the Cash
Settlement Averaging Period. Promptly after such determination of the Daily Settlement
Amounts or the Daily Conversion Values, as the case may be, and the amount of cash deliverable
in lieu of any fractional share in accordance with Section 4.03(d), the Company shall notify
the Trustee in writing and the Conversion Agent (if other than the Trustee) of the Daily
Settlement Amounts or the Daily Conversion Values, as the case may be, and the amount of cash
deliverable in lieu of fractional shares of Common Stock. The Trustee and the Conversion
Agents (if other than the Trustee) shall have no responsibility for any such determination.

     (c) Upon the conversion of any Notes, the Holder of such Notes shall not be entitled to
receive any separate cash payment for accrued and unpaid interest, if any, except to the
extent specified below. The Company’s delivery to the Holder of cash, shares of Common Stock,
or a combination of cash and shares of Common Stock, together with any cash payment for any
fractional share of Common Stock, if applicable, issuable upon conversion shall be deemed to
satisfy in full the Company’s obligation to pay the principal amount of the Notes so converted
and accrued and unpaid interest, if any, to, but not including, the Conversion Date. As a
result, accrued and unpaid interest, if any, to, but not including, the Conversion Date shall
be deemed to be paid in full rather than cancelled,

28

 

extinguished or forfeited. Upon a
conversion of Notes into a combination of cash and shares of Common Stock, accrued and unpaid
interest shall be deemed to be paid first out of any cash paid upon such conversion.
Notwithstanding the foregoing, if Notes are converted after the close of business on any
Regular Record Date and prior to the open of business on the immediately following Interest
Payment Date, Holders of such Notes at the close of business on such Regular Record Date shall
receive the interest payable on such Notes on the corresponding Interest Payment Date
notwithstanding the conversion. Notes surrendered for conversion during the period from the
close of business on any Regular Record Date to the open of business on the immediately
following Interest Payment Date must be accompanied by funds equal to the amount of interest
payable on the Notes so converted (whether or not the Holder was a Holder of record on such
Regular Record Date); provided that no such payment need be made on Notes converted:

               (A) after the close of business on the Regular Record Date immediately preceding the Stated
Maturity,

               (B) if the Company has specified a Fundamental Change Purchase Date that is after a Regular
Record Date and on or prior to the Business Day immediately following the corresponding Interest
Payment Date, or

               (C) to the extent of any Defaulted Amounts, if any Defaulted Amounts exist at the time of
conversion with respect to such Note.

     (d) The Company shall not issue any fractional share of Common Stock upon conversion of
the Notes and shall instead pay cash in lieu of any fractional share of Common Stock issuable
upon conversion based on (i) the Daily VWAP of the Common Stock on the relevant Conversion
Date (in the case of Physical Settlement) or (ii) the Daily VWAP on the last Trading Day of
the relevant Cash Settlement Averaging Period (in the case of Combination Settlement). For
each Note surrendered for conversion, if the Company has elected Combination Settlement, the
full number of shares that shall be issued upon conversion thereof shall be computed on the
basis of the aggregate Daily Settlement Amounts for the applicable Cash Settlement Averaging
Period and any fractional share remaining after such computation shall be paid in cash. In
addition, if more than one Note shall be surrendered for conversion at one time by the same
Holder, the number of full shares that shall be issued upon conversion thereof shall be
computed on the basis of the aggregate principal amount of the Notes (or specified portions
thereof) so surrendered.

               Section 4.04
Adjustment of Conversion Rate.
The Conversion Rate shall be adjusted from time to time by the Company if any of the following
events occurs, except that the Company shall not make any adjustment to the Conversion Rate if
Holders of the Notes participate (other than in the case of a share split or share combination), at
the same time and upon the same terms as holders of the Common Stock and solely as a result of
holding the Notes, in any of the transactions described in this Section 4.04, without having to
convert their Notes, as if such Holders held a number of shares of Common Stock equal to the
applicable Conversion Rate, multiplied by the principal amount (expressed in thousands) of Notes
held by such Holder. If any dividend, distribution or issuance described in this Section 4.04 is
declared but not so paid or made, or any share split or combination described below in paragraph
(a) is announced but the

29

 

outstanding shares of Common Stock are not split or combined, as the case
may be, the Conversion Rate shall be immediately readjusted, effective as of the date the Board of
Directors determines not to pay or make such dividend, distribution or issuance, or not to split or
combine the outstanding shares of Common Stock, as the case may be, to the Conversion Rate that
would then be in effect if such dividend, distribution, issuance, share split or share combination
had not been declared or announced.

     (a) If the Company exclusively issues to all or substantially all holders of the Common
Stock shares of Common Stock as a dividend or distribution on shares of Common Stock, or if
the Company effects a share split or share combination, the Conversion Rate shall be adjusted
based on the following formula:

	 	 	 	 	 	 	 	 	 	 	 

	CR1

	 	=
	 	CR0
	 	x
	 	OS1
	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	OS0	 	 

where,

			
	     CR0 =	 	the Conversion Rate in effect immediately prior to the open of business on
the Ex-Dividend Date of such dividend or distribution, or immediately prior to the open
of business on the effective date of such share split or share combination, as
applicable;

			
	     CR1 =	 	the Conversion Rate in effect immediately after the open of business on
such Ex-Dividend Date or such effective date;

			
	     OS0 =	 	the number of shares of Common Stock outstanding immediately prior to the
open of business on such Ex-Dividend Date or such effective date; and

			
	     OS1 =	 	the number of shares of Common Stock outstanding immediately after giving
effect to such dividend, distribution, share split or share combination.

     Any adjustment made under this Section 4.04(a) shall become effective immediately after the
open of business on such Ex-Dividend Date or effective date.

     (b) If the Company issues to all or substantially all holders of its Common Stock any
rights, options or warrants entitling them for a period of not more than 45 calendar days
after the date of such issuance to subscribe for or purchase shares of the Common Stock, at a
price per share less than the average of the Last Reported Sale Prices of the Common Stock for
the 10 consecutive Trading Day period ending on, and including, the Trading Day immediately
preceding the date of announcement of such issuance, the Conversion Rate shall be increased
based on the following formula:

	 	 	 	 	 	 	 	 	 	 	 

	CR1

	 	=
	 	CR0
	 	x
	 	OS0  +  X
	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	OS0  +  Y	 	 

30

 

where,

			
	     CR0 =	 	the Conversion Rate in effect immediately prior to the open of business on
the Ex-Dividend Date for such issuance;

			
	     CR1 =	 	the Conversion Rate in effect immediately after the open of business on
such Ex-Dividend Date;

			
	     OS0 =	 	the number of shares of Common Stock outstanding immediately prior to the
open of business on such Ex-Dividend Date;

			
	     X =	 	the total number of shares of Common Stock issuable pursuant to such rights,
options or warrants; and

			
	     Y =	 	the number of shares of Common Stock equal to the aggregate price payable to
exercise such rights, options or warrants divided by the average of the Last Reported
Sale Prices of the Common Stock over the 10 consecutive Trading Day period ending on,
and including, the Trading Day immediately preceding the date of announcement of the
issuance of such rights, options or warrants.

     Any increase made under this Section 4.04(b) shall be made successively whenever any such
rights, options or warrants are issued and shall become effective immediately after the open of
business on the Ex-Dividend Date for such issuance. To the extent that such rights, options or
warrants are not exercised prior to their expiration or shares of the Common Stock are not
delivered upon exercise of such rights, options or warrants, the Conversion Rate shall be decreased
to the Conversion Rate that would then be in effect had the increase with respect to the issuance
of such rights, options or warrants been made on the basis of delivery of only the number of shares
of Common Stock actually delivered.

     For purposes of this Section 4.04(b), in determining whether any rights, options or warrants
entitle the holders to subscribe for or purchase shares of the Common Stock at less than such
average of the Last Reported Sale Prices of the Common Stock for the 10 consecutive Trading Day
period ending on the Trading Day immediately preceding the date of announcement for such issuance,
and in determining the aggregate offering price of such shares of the Common Stock, there shall be
taken into account any consideration received by the Company for such rights, options or warrants
and any amount payable on exercise or conversion thereof and the value of such consideration, if
other than cash, to be determined by the Board of Directors.

     (c) If the Company distributes shares of its Capital Stock, evidences of its
indebtedness, other assets or property of the Company or rights, options or warrants to
acquire its Capital Stock or other securities, to all or substantially all holders of the
Common Stock, excluding

          (1) dividends or, distributions as to which an adjustment was effected pursuant to Section
4.04(a) or Section 4.04(b);

          (2) dividends or distributions paid exclusively in cash as to the provisions set forth in
Section 4.04(d) shall apply;

31

 

          (3) Spin-Offs as to which the provisions set forth below in this Section 4.04(c) shall apply;
and

          (4) any dividends or distributions in connection with a Merger Event that is included in
Reference Property.

(any of such shares of Capital Stock, evidences of indebtedness, other assets or property or
rights, options or warrants to acquire Capital Stock or other securities of the Company, the
“Distributed Property”), then the Conversion Rate shall be increased based on the following
formula:

	 	 	 	 	 	 	 	 	 	 	 

	CR1

	 	=
	 	CR0
	 	x
	 	SP0
	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	SP0  -  FMV	 	 

where,

			
	     CR0 =	 	the Conversion Rate in effect immediately prior to the open of business on
the Ex-Dividend Date for such distribution;

			
	     CR1 =	 	the Conversion Rate in effect immediately after the open of business on
such Ex-Dividend Date;

			
	     SP0 =	 	the average of the Last Reported Sale Prices of the Common Stock over the
10 consecutive Trading Day period ending on, and including, the Trading Day immediately
preceding the Ex-Dividend Date for such distribution; and

			
	     FMV =	 	the fair market value (as determined by the Board of Directors) of the
Distributed Property distributed with respect to each outstanding share of the Common
Stock on the Ex-Dividend Date for such distribution.

     If the Board of Directors determines the “FMV” (as defined above) of any distribution for
purposes of this Section 4.04(c) by reference to the actual or when-issued trading market for any
securities, it shall in doing so consider the prices in such market over the same period used in
computing the Last Reported Sale Prices of the Common Stock over the 10 consecutive Trading Day
period ending on the Trading Day immediately preceding the Ex-Dividend Date for such distribution.

     Notwithstanding the foregoing, if “FMV” (as defined above) is equal to or greater than
“SP0” (as defined above), in lieu of the foregoing increase, each Holder of Notes shall
receive, in respect of each $1,000 principal amount thereof, at the same time and upon the same
terms as holders of the Common Stock receive the Distributed Property, the amount and kind of the
Distributed Property that such Holder would have received as if such Holder had owned a number of
shares of Common Stock equal to the Conversion Rate in effect on the Ex-Dividend Date for the
distribution.

     Any increase made under the above portion of this Section 4.04(c) shall become effective
immediately after the open of business on the Ex-Dividend Date for such distribution.

32

 

     With respect to an adjustment to the Conversion Rate pursuant to this Section 4.04(c) where
there has been a payment of a dividend or other distribution on the Common Stock of shares of
Capital Stock of any class or series, or similar equity interest, of or relating to a Subsidiary or
other business unit of the Company, and such Capital Stock or similar equity interest is listed or
quoted (or will be listed or quoted upon consummation of the distribution) on a U.S. national
securities exchange or reasonably comparable non-U.S. equivalent (a “Spin-Off”), the Conversion
Rate shall be increased based on the following formula:

	 	 	 	 	 	 	 	 	 	 	 

	CR1

	 	=
	 	CR0
	 	x
	 	FMV0  +  MP0
	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	MP0	 	 

where,

			
	     CR0 =	 	the Conversion Rate in effect immediately prior to the open of business on
the Ex-Dividend Date for such Spin-Off;

			
	     CR1 =	 	the Conversion Rate in effect immediately after the open of business on the
Ex-Dividend Date for such Spin-Off;

			
	     FMV0 =	 	the average of the Last Reported Sale Prices of the Capital Stock or
similar equity interest distributed to holders of Common Stock applicable to one share
of Common Stock (determined for purposes of the definition of Last Reported Sale Price
as if such Capital Stock or similar equity interest were the Common Stock) over the
first 10 consecutive Trading Day period commencing on, and including, the effective
date of the Spin-Off (the “Valuation Period”); and

			
	     MP0 =	 	the average of the Last Reported Sale Prices of Common Stock over the
Valuation Period.

     The adjustment to the Conversion Rate made under the preceding paragraph shall occur on the
last day of the Valuation Period but will be given effect as of the Ex-Dividend Date for the
Spin-Off; provided that in respect of any conversion for which the first Trading Day of the Cash
Settlement Averaging Period occurs after the effective date for a Spin-Off, but during the
Valuation Period for such Spin-Off, references in the portion of this Section 4.04(c) related to
Spin-Offs to 10 Trading Days shall be deemed replaced with such lesser number of Trading Days as
have elapsed since, and including, the effective date of such Spin-Off but before the first Trading
Day of the Cash Settlement Averaging Period; provided further that if one or more Trading Days of
any Cash Settlement Averaging Period occurs on or after the Ex-Dividend Date for a Spin-Off, but on
or prior to the first Trading Day of the Valuation Period (which is the effective date for such
Spin-Off), such Cash Settlement Averaging Period will be suspended on the first such Trading Day
and will resume on the second Trading Day of the Valuation Period for such Spin-Off, with
references in this portion of Section 4.04(c) related to Spin-Offs to 10 Trading Days deemed
replaced with references to one (1) Trading Day.

     For the purposes of this Section 4.04(c) (and subject in all respects to Section 4.12),
rights, options or warrants distributed by the Company to all holders of its Common Stock entitling
them to subscribe for or purchase shares of the Company’s Capital Stock (either initially

33

 

or under
certain circumstances), which rights, options or warrants, until the occurrence of a specified
event or events (a “Trigger Event”): (1) are deemed to be transferred with such shares of Common
Stock; (2) are not exercisable; and (3) are also issued in respect of future issuances of Common
Stock, shall be deemed not to have been distributed for purposes of this Section 4.04(c), (and no
adjustment to the Conversion Rate under this Section 4.04(c) will be required) until the occurrence
of the earliest Trigger Event, whereupon such rights, options or warrants shall be deemed to have
been distributed and an appropriate adjustment (if any is required) to the Conversion Rate shall be
made under this Section 4.04(c). If any such right, option or warrant, including any such existing
rights, options or warrants distributed prior to the date of this Supplemental Indenture, are
subject to events, upon the occurrence of which such rights, options or warrants become exercisable
to purchase different securities, evidences of indebtedness or other assets, then the date of the
occurrence of any and each such event shall be deemed to be the date of distribution and
Ex-Dividend Date of such deemed distribution (in which case the original rights, options or
warrants shall be deemed to terminate and expire on such date without exercise by any of the
holders). In addition, in the event of any distribution or deemed distribution of rights, options
or warrants, or any Trigger Event or other event (of the type described in the preceding sentence)
with respect thereto that was counted for purposes of calculating a distribution amount for which
an adjustment to the Conversion Rate under this Section 4.04(c) was made, (1) in the case of any
such rights, options or warrants which shall all
have been redeemed or purchased without exercise by any Holders thereof, upon such final
redemption or repurchase (x) the Conversion Rate shall be readjusted as if such rights, options or
warrants had not been issued and (y) the Conversion Rate shall then again be readjusted to give
effect to such distribution, deemed distribution or Trigger Event, as the case may be, as though it
were a cash distribution, equal to the per share redemption or purchase price received by holders
of Common Stock with respect to such rights, options or warrants (assuming each such holder had
retained such rights, options or warrants), made to all holders of Common Stock as of the date of
such redemption or purchase, and (2) in the case of such rights, options or warrants which shall
have expired or been terminated without exercise by any holders thereof, the Conversion Rate shall
be readjusted as if such rights and warrants had not been issued.

     For purposes of this Section 4.04(c) and subsections (a) and (b) of this Section 4.04, any
dividend or distribution to which this Section 4.04(c) applies which also includes one or both of:

     (a) a dividend or distribution of shares of Common Stock to which Section 4.04(a)
applies (the “Clause A Distribution”);

     (b) a dividend or distribution of rights, options or warrants to which Section 4.04(b)
applies (the “Clause B Distribution”),

then (1) such dividend or distribution, other than the Clause A Distribution and the Clause B
Distribution, shall be deemed to be a dividend or distribution to which this Section 4.04(c)
applies (the “Clause C Distribution”) and any Conversion Rate adjustment required by this Section
4.04(c) with respect thereto shall then be made, and (2) the Clause A Distribution and Clause B
Distribution shall be deemed to immediately follow the Clause C Distribution and any Conversion
Rate adjustment required by Section 4.04(a) and Section 4.04(b) with respect thereto shall then be
made, except that, if determined by the Company, (I) the “Ex-Dividend Date” of the Clause A
Distribution and the Clause B Distribution shall be deemed to be the Ex-Dividend

34

 

Date of the Clause
C Distribution and (II) any shares of Common Stock included in the Clause A Distribution or Clause
B Distribution shall be deemed not to be “outstanding immediately prior to the open of business on
such Ex-Dividend Date or such effective date” within the meaning of Section 4.04(a) or “outstanding
immediately prior to the open of business on such Ex-Dividend Date” within the meaning of Section
4.04(b).

     (d) If any cash dividend or distribution is made to all or substantially all holders of
the Common Stock, other than a regular, quarterly cash dividend that does not exceed the
Dividend Threshold, the Conversion Rate shall be adjusted based on the following formula:

	 	 	 	 	 	 	 	 	 	 	 

	CR1

	 	=
	 	CR0
	 	x
	 	SP0  -  T
	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	SP0  -  C	 	 

where,

			
	     CR0 =	 	the Conversion Rate in effect immediately prior to the open of business on
the Ex-Dividend Date for such dividend or distribution;

			
	     CR1 =	 	the Conversion Rate in effect immediately after the open of business on the
Ex-Dividend Date for such dividend or distribution;

			
	     SP0 =	 	the average of the Last Reported Sale Prices of the Common Stock over 10
consecutive Trading Day period ending on, and including, the Trading Day immediately
preceding the Ex-Dividend Date for such dividend or distribution (or, if the Company
declares such a dividend or distribution less than 11 Trading Days prior to such
Ex-Dividend Date, 10 shall be replaced with a smaller number of Trading Days that will
have occurred after, and not including, such declaration date, and prior to, and not
including, such Ex-Dividend Date);

			
	     T =	 	the Dividend Threshold in effect on the Ex-Dividend Date for such dividend or
distribution; provided that if the dividend or distribution is not a regular quarterly
cash dividend, the Dividend Threshold shall be deemed to be zero; and

			
	     C =	 	the amount in cash per share that the Company distributes to holders of the
Common Stock.

     Any increase pursuant to this Section 4.04(d) shall become effective immediately after the
open of business on the Ex-Dividend Date for such dividend or distribution.

     Notwithstanding the foregoing, if “C” (as defined above) is equal to or greater than
“SP0” (as defined above), in lieu of the foregoing adjustment, each Holder shall
receive, for each $1,000 principal amount of Notes, at the same time and upon the same terms as
holders of shares of the Common Stock, the amount of cash that such Holder would have received if
such Holder had owned a number of shares of Common Stock equal to the Conversion Rate on the
Ex-Dividend Date for such cash dividend or distribution.

35

 

     (e) If the Company or any of its Subsidiaries make a payment in respect of a tender offer
or exchange offer for the Common Stock, to the extent that the cash and value of any other
consideration included in the payment per share of the Common Stock exceeds the Last Reported
Sale Price of the Common Stock on the Trading Day next succeeding the last date on which
tenders or exchanges may be made pursuant to such tender or exchange offer (the “Expiration
Date”), the Conversion Rate shall be increased based on the following formula:

	 	 	 	 	 	 	 	 	 	 	 

	CR1

	 	=
	 	CR0
	 	x
	 	AC  +  (SP1  x  OS1)	 	 
	 

	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	OS0  x  SP1	 	 

where,

			
	     CR0 =	 	the Conversion Rate in effect immediately prior to the close of business on
the 10th Trading Day immediately following, and including, the Trading Day next
succeeding the Expiration Date;

			
	     CR1 =	 	the Conversion Rate in effect immediately after the close of business on
the 10th Trading Day immediately following, and including, the Trading Day next
succeeding the Expiration Date;

			
	     AC =	 	the aggregate value of all cash and any other consideration (as determined by
the Board of Directors) paid or payable for shares of Common Stock purchased in such
tender offer or exchange offer;

			
	     OS0 =	 	the number of shares of Common Stock outstanding immediately prior to the
Expiration Date (prior to giving effect to the purchase of all shares accepted for
purchase or exchange in such tender offer or exchange offer);

			
	     OS1 =	 	the number of shares of Common Stock outstanding immediately after the
Expiration Date (after giving effect to the purchase of all shares accepted for
purchase or exchange in such tender or exchange offer); and

			
	     SP1 =	 	the average of the Last Reported Sale Prices of the Common Stock over the
10 consecutive Trading Day period commencing on, and including, the Trading Day next
succeeding the Expiration Date.

     The adjustment to the Conversion Rate under this Section 4.04(e) shall occur at the close of
business on the 10th Trading Day immediately following, and including, the Trading Day next
succeeding the Expiration Date; provided that for purposes of determining the applicable Conversion
Rate in respect of any conversion during the 10 Trading Day period commencing on, and including,
the Trading Day next succeeding the Expiration Date, references in this Section 4.04(e) with
respect to 10 Trading Days shall be deemed replaced with such lesser number of Trading Days as have
elapsed from, and including, the Trading Day next succeeding the Expiration Date, but excluding,
the Conversion Date.

     (f) To the extent permitted by law and any applicable stock exchange rules, the Company
from time to time may increase the Conversion Rate by any amount for a period

36

 

of at least 20
Business Days. Whenever the Conversion Rate is increased pursuant to this Section 4.04(f),
the Company shall mail to Holders of record of the Notes a notice of the increase at least 10
days prior to the date the increased Conversion Rate takes effect, and such notice shall state
the increased Conversion Rate and the period during which it will be in effect.

     (g) The Company may (but shall not be required to) increase the Conversion Rate, in
addition to any adjustments pursuant to Section 4.04(a), 4.04(b), 4.04(c), 4.04(d), 4.04(e) or
4.04(f), if the Board of Directors considers such increase to be advisable to avoid or
diminish any income tax to holders of Common Stock or rights to purchase shares of Common
Stock in connection with a dividend or distribution of shares (or rights to acquire shares) or
similar event.

     (h) If a Holder converts a Note and, on any Trading Day during the applicable Cash
Settlement Averaging Period:

          (1) shares of Common Stock are deliverable as part of the Daily Settlement Amount for such
Trading Day;

          (2) an Adjustment Event has occurred, but will not result in an adjustment to the Conversion
Rate for such Trading Day for such Holder; and

          (3) the shares of Common Stock that the Holder shall receive as part of the Daily Settlement
Amount for such Trading Day will not be entitled to participate in the distribution or transaction
requiring the adjustment (because such shares were not held by such Holder on the record date
corresponding to such distribution or transaction or otherwise),

then the Company will adjust the number of shares of Common Stock or cash deliverable to such
Holder as part of the Daily Settlement Amount for such Trading Day in a manner that appropriately
reflects the relevant distribution or transaction requiring adjustment.

     (i) All calculations under this Article 4 shall be made by the Company and shall be made
to the nearest cent (including, in the case of any adjustment to the Conversion Rate, the
resulting adjustment to the Conversion Price) or to the nearest one ten-thousandth of a share.
No adjustment to the Conversion Rate shall be made pursuant to Sections 4.04(a) — (e) in such
a manner as to result in the reduction to the Conversion Price to less than the par value per
share of the Common Stock.

     (j) Whenever the Conversion Rate is adjusted as herein provided, the Company shall
promptly file with the Trustee and any Conversion Agent an Officers’ Certificate setting forth
the Conversion Rate after such adjustment and setting forth a brief statement of the facts
requiring such adjustment. Unless and until a Responsible Officer of the Trustee shall have
received such Officers’ Certificate, the Trustee shall not be deemed to have knowledge of any
adjustment of the Conversion Rate and may assume without inquiry that the last Conversion Rate
of which it has knowledge is still in effect. Promptly after delivery of such certificate,
the Company shall prepare a notice of such adjustment of the
 Conversion Rate setting forth the
adjusted Conversion Rate and the date on which each adjustment becomes effective and shall
mail such notice of such adjustment of the

37

 

Conversion Rate to each Holder of the Notes.
Failure to deliver such notice shall not affect the legality or validity of any such
adjustment.

     (k) For purposes of this Section 4.04, the number of shares of Common Stock at any time
outstanding shall not include shares held in the treasury of the Company so long as the
Company does not pay any dividend or make any distribution on shares of Common Stock held in
the treasury of the Company, but shall include shares issuable in respect of scrip
certificates issued in lieu of fractions of shares of Common Stock.

     (l) Except as stated in this Section 4.04 and Section 4.12, the Company will not adjust
the Conversion Rate for the issuance of shares of the Common Stock or any securities
convertible into or exchangeable for shares of the Common Stock or
the right to purchase shares of the Common Stock or such convertible or exchangeable securities. In addition,
notwithstanding any of the foregoing, the applicable Conversion Rate will not be adjusted:

          (1) upon the issuance of any shares of Common Stock pursuant to any present or future plan
providing for the reinvestment of dividends or interest payable on the Company’s securities and the
investment of additional optional amounts in shares of Common Stock under any plan;

          (2) upon the issuance of any shares of Common Stock or options or rights to purchase those
shares to or pursuant to any present or future employee, director or consultant benefit or deferred
compensation plan or program of or assumed by the Company or any of its Subsidiaries;

          (3) stock repurchases that are not tender offers referred to Section 4.04(e), including
structured or derivative transactions, pursuant to a stock repurchase program approved by the Board
of Directors;

          (4) upon the issuance of any shares of Common Stock pursuant to any option, warrant, right or
exercisable, exchangeable or convertible security not described in clause (2) of this Section
4.04(l) and outstanding as of the date the Notes were first issued;

          (5) for a change in the par value of the Common Stock; or

          (6) for accrued and unpaid interest on the Notes, if any.

     (m) Adjustments to the Conversion Rate will be calculated to the nearest 1/10,000th of a
share. No adjustment will be made pursuant to this Section 4.04 in the Conversion Rate unless
the adjustment would require a change of at least 1% in the Conversion Rate. However, any
such adjustments less than 1% of the Conversion Rate will be carried forward and the Company
will make such carried forward adjustment to the Conversion Rate on the Conversion Date for
any Notes and on each Trading Day of a Cash Settlement Averaging Period with respect to any
Conversion Date for any Notes, regardless of whether the aggregate adjustment is less than 1%.

38

 

               Section 4.05 Certain Other Adjustments. Whenever any provision of the Indenture requires the Company to calculate the Last Reported
Sale Prices, the Daily VWAPs, the Daily Conversion Values or the Daily Settlement Amounts over a
span of multiple days (including any Cash Settlement Averaging Period), the Company shall make
appropriate adjustments to each to account for any adjustment to the Conversion Rate that becomes
effective, or any event requiring an adjustment to the Conversion Rate where the Ex-Dividend Date
of the event occurs, at any time during the period when the Last Reported Sale Prices, the Daily
VWAPs, the Daily Conversion Values or the Daily Settlement Amounts are to be calculated.

               Section 4.06 Adjustment to Conversion Rate Upon Conversion in Connection with a Make-Whole
Fundamental Change. (a) If a Make-Whole Fundamental Change occurs and a Holder elects to convert its Notes in
connection with such Make-Whole Fundamental Change, the Company shall, under certain
circumstances, increase the Conversion Rate for the Notes so surrendered for
conversion by a number of additional shares of Common Stock (the “Additional Shares”), as
described below. A conversion of Notes shall be deemed for these purposes to be “in
connection with” such Make-Whole Fundamental Change if the relevant Conversion Notice is
received by the Conversion Agent from, and including, the Effective Date of the Make-Whole
Fundamental Change up to, and including, the Business Day immediately prior to the related
Fundamental Change Purchase Date (or, in the case of a Make-Whole Fundamental Change that
would have been a Fundamental Change but for the first proviso in clause (2) of the definition
thereof, the 35th Trading Day immediately following the Effective Date of such Make-Whole
Fundamental Change).

     (b) Upon surrender of Notes for conversion in connection with a Make-Whole Fundamental
Change, the Company shall satisfy the related Conversion Obligation based on the Settlement
Method then in effect in accordance with Section 4.03; provided, however, that if, at the
effective time of a Make-Whole Fundamental Change described in Clause (2) of the definition of
Fundamental Change, the Reference Property is comprised entirely of cash, then, for any
conversion of Notes following the Effective Date of such Make-Whole Fundamental Change, the
Conversion Obligation shall be calculated based solely on the Stock Price for the Make-Whole
Fundamental Change and shall be deemed to be an amount equal to the applicable Conversion Rate
(as increased by the number of Additional Shares, if any) multiplied by such Stock Price. In
such event, the Conversion Obligation shall be determined and paid to Holders in cash on the
third Business Day following the applicable Conversion Date.

     (c) The number of Additional Shares, if any, by which the Conversion Rate will be
increased shall be determined by reference to the table attached as Schedule A hereto,
based on the date on which the Make-Whole Fundamental Change occurs or becomes effective (the
“Effective Date”) and the price (the “Stock Price”) paid (or deemed paid) per share of the
Common Stock in the Make-Whole Fundamental Change. If the holders of the Common Stock receive
only cash in a Make-Whole Fundamental Change described in clause (2) of the definition of
Fundamental Change, the Stock Price shall be the cash amount paid per share. Otherwise, the
Stock Price shall be the average of the Last Reported Sale Prices of the Common Stock over the
ten consecutive Trading Day period ending on, and including, the Trading Day immediately
preceding the Effective Date of the Make-

39

 

Whole Fundamental Change. The Board of Directors
shall make appropriate adjustments to the Stock Price, in its good faith determination, to
account for any adjustment to the Conversion Rate that becomes effective, or any event
requiring an adjustment to the Conversion Rate where the Ex-Dividend Date of the event occurs,
during such five consecutive Trading Day period.

     The exact Stock Prices and Effective Dates may not be set forth in the table in Schedule
A, in which case:

          (1) If the Stock Price is between two Stock Prices in the table or the Effective Date is
between two Effective Dates in the table, the number of Additional Shares shall be determined by a
straight-line interpolation between the number of Additional Shares set forth for the higher and
lower Stock Prices and the earlier and later Effective Dates, as applicable, based on a 365-day
year.

          (2) If the Stock Price is greater than $180.00 per share (subject to adjustment in the same
manner as the Stock Prices set forth in the column headings of the table in Schedule A
pursuant to Section 4.06(d)), the Conversion Rate shall not be increased.

          (3) If the Stock Price is less than $53.32 per share (subject to adjustments in the same
manner as the Stock Prices set forth in the column headings of the table in Schedule A
pursuant to Section 4.06(d)), the Conversion Rate shall not be increased.

Notwithstanding the foregoing, in no event shall the total number of shares of Common Stock
issuable upon conversion exceed 18.7546 shares per $1,000 principal amount of Notes, subject to
adjustments in the same manner as the Conversion Rate as set forth in Section 4.04.

     (d) The Stock Prices set forth in the column headings of the table in Schedule A
hereto shall be adjusted as of any date on which the Conversion Rate of the Notes is otherwise
adjusted. The adjusted Stock Prices shall equal the Stock Prices applicable immediately prior
to such adjustment, multiplied by a fraction, the numerator of which is the Conversion Rate
immediately prior to such adjustment giving rise to the Stock Price adjustment and the
denominator of which is the Conversion Rate as so adjusted. The number of Additional Shares
set forth in such table shall be adjusted in the same manner and at the same time as the
Conversion Rate as set forth in Section 4.04.

     (e) The Company shall notify the Holders of the Effective Date of any Make-Whole
Fundamental Change and issue a press release announcing such Effective Date no later than five
Business Days after such Effective Date.

               Section 4.07
Effect of Recapitalization, Reclassification, Consolidation,
Merger or Sale. (a) In the case of:

          (1) any recapitalization, reclassification or change of the Common Stock (other than changes
resulting from a subdivision or combination);

          (2) any consolidation, merger or share exchange involving the Company; or

40

 

          (3) any sale, conveyance, transfer, lease or disposition to a third party of the consolidated
assets of the Company and its Subsidiaries taken as a whole;

in each case as a result of which the Common Stock would be converted into, or exchanged for,
stock, other securities, or other property or assets (including cash or any combination thereof)
(any such event, a “Merger Event”), then, at the effective time of such Merger Event, the right to
convert each $1,000 principal amount of Notes based on the Common Stock will, without the consent
of the Holders of the Notes, shall be changed into a right to convert such principal amount of
Notes based on the kind and amount of shares of stock, other securities or other property or assets
(including cash or any combination thereof) that a holder of a number of shares of Common Stock
equal to the Conversion Rate immediately prior to such Merger Event would have owned or been
entitled to receive (the “Reference Property”, with each “unit of Reference Property” meaning the
type and amount of Reference Property that a holder of one
share of Common Stock is entitled to receive) and, prior to or at the effective time of such Merger
Event, the Company or the successor or purchasing person, as the case may be, shall execute with
the Trustee a supplemental indenture (which shall comply with the Trust Indenture Act as in force
at the date of execution of such supplemental indenture) providing for such change in the right to
convert each $1,000 principal amount of Notes; provided, however, that (i) the Company shall
continue to have the right to elect the Settlement Method upon conversion of the Notes in
accordance with Section 4.03 and (ii) (x) any amount payable in cash upon conversion of the Notes
in accordance with Section 4.03 shall continue to be payable in cash, (y) any shares of Common
Stock that the Company would have been required to deliver upon conversion of the Notes in
accordance with Section 4.03 shall instead be deliverable in the amount and type of Reference
Property that a holder of that number of shares of Common Stock would have received in such Merger
Event and (z) the Daily VWAP shall be calculated based on the value of a unit of Reference
Property; provided however that if the Holders of the Common Stock receive only cash in such Merger
Event, the amount deliverable upon conversion shall equal, for each $1,000 principal amount of
Notes, the Conversion Rate in effect on the Conversion Date multiplied by the price paid per share
of the Common Stock in such Merger Event and settlement will occur on the third Business Day
following the Conversion Date.

     If, as a result of the Merger Event, each share of Common Stock is converted into the right to
receive more than a single type of consideration (determined based in part upon any form of
stockholder election), then (x) the Reference Property based on which the Notes will be convertible
will be deemed to be the weighted average of the types and amounts of consideration received by the
holders of Common Stock that affirmatively make such an election, and (y) the unit of Reference
Property for purposes of the foregoing sentence shall refer to the consideration referred to in
clause (x) attributable to one share of Common Stock. The Company shall notify Holders, the
Trustee and the Conversion Agent (if other than the Trustee) of such weighted average as soon as
practicable after such determination is made.

     The Company shall not become a party to any such Merger Event unless its terms are consistent
with this Section 4.07. Such supplemental indenture described in the second immediately preceding
paragraph shall provide for adjustments which shall be as nearly equivalent to the adjustments
provided for in this Article 4 in the judgment of the Board of Directors or the board of directors
of the successor person. If, in the case of any such Merger Event, the Reference Property
receivable thereupon by a holder of Common Stock includes

41

 

shares of stock, securities or other
property or assets (including cash or any combination thereof) of a person other than the successor
or purchasing person, as the case may be, in such Merger Event, then such supplemental indenture
shall also be executed by such other person.

     (b) The Company shall cause notice of the execution of such supplemental indenture to be
mailed to each Holder, at the address of such Holder as it appears on the register of the
Notes maintained by the Registrar, within 20 days after execution thereof. Failure to deliver
such notice shall not affect the legality or validity of such supplemental indenture. The
above provisions of this Section 4.07 shall similarly apply to successive Merger Events. If
this Section 4.07 applies to any Merger Event, Section 4.04 shall not apply.

     (c) In connection with any Merger Event, the Dividend Threshold shall be subject to
adjustment as described in clause (1), clause (2) or clause (3) below, as the case may be.

          (1) In the case of a Merger Event in which the Reference Property (determined, as appropriate,
pursuant to the second paragraph of subsection (a) above and excluding any dissenters’ appraisal
rights) is composed entirely of shares of common stock (the “Merger Common Stock”), the Dividend
Threshold at the effective time of such Merger Event shall be equal to (x) the Dividend Threshold
immediately prior to the effective time of such Merger Event, divided by (y) the number of shares
of Merger Common Stock that a holder of one share of Common Stock would receive in such Merger
Event (such quotient rounded down to nearest cent) (subject to adjustment as provided in 4.04(d)).

          (2) In the case of a Merger Event in which the Reference Property (determined, as appropriate,
pursuant to the second paragraph of subsection (a) above and excluding any dissenters’ appraisal
rights) is composed in part of shares of Merger Common Stock, the Dividend Threshold at the
effective time of such Merger Event shall be equal to (x) the Dividend Threshold immediately prior
to the effective time of such Merger Event, multiplied by (y) the Merger Valuation Percentage for
such Merger Event (such product rounded down to nearest cent) (subject to adjustment as provided in
4.04(d)).

          (3) For the avoidance of doubt, in the case of a Merger Event in which the Reference Property
(determined, as appropriate, pursuant to the second paragraph of subsection (a) above and excluding
any dissenters’ appraisal rights) is composed entirely of consideration other than shares of common
stock, the Dividend Threshold at and after the effective time of such Merger Event shall be equal
to zero.

     (d) For purposes of subsection (c) of this Section 4.07, the following terms shall have
the following meanings:

          (1) The “Merger Valuation Percentage” for any Merger Event shall be equal to (x) the
arithmetic average of the Last Reported Sale Prices of one share of such Merger Common Stock over
the relevant Merger Valuation Period (determined as if references to “Common Stock” in the
definition of “Last Reported Sale Price” were references to the “Merger

42

 

Common Stock” for such
Merger Event), divided by (y) the arithmetic average of the Last Reported Sale Prices of one share
of Common Stock over the relevant Merger Valuation Period.

          (2) The “Merger Valuation Period” for any Merger Event means the five consecutive Trading Day
period immediately preceding, but excluding, the effective date for such Merger Event.

               Section 4.08 Taxes on Shares Issued
The Company shall pay any documentary, stamp or similar issue or transfer tax due on the issue
or delivery of shares of Common Stock on conversion of Notes pursuant hereto; provided, however,
that if such documentary, stamp or similar issue or transfer tax is due because the Holder or
beneficial owner of such Notes has requested that shares of Common Stock be issued in a name other
than that of the Holder or beneficial owner of the converted Notes, then
such taxes shall be paid by such Holder or beneficial owner, and the Company shall not be
required to issue or deliver any stock certificate evidencing such shares unless and until such
Holder or beneficial owner shall have paid to the Company the amount of such tax or shall have
established to the satisfaction of the Company that such tax has been paid.

               Section 4.09 Reservation of Shares; Shares to be Fully Paid; Compliance With Governmental
Requirements; Listing of Common Stock
The Company shall reserve, out of its authorized but unissued shares or shares held in
treasury, sufficient shares of Common Stock to satisfy conversion of the Notes from time to time as
such Notes are presented for conversion (assuming that, at the time of the computation of such
number of shares or securities, all such Notes would be converted by a single Holder and that
Physical Settlement is applicable).

     The Company covenants that all shares of Common Stock that may be issued upon conversion of
Notes shall be newly issued shares or treasury shares, shall be duly authorized, validly issued,
fully paid and non-assessable and shall be free from preemptive rights and free from any tax, lien
or charge (other than those created by the Holder).

     The Company shall list or cause to have quoted any shares of Common Stock to be issued upon
conversion of Notes on each national securities exchange or over-the-counter or other domestic
market on which the Common Stock is then listed or quoted.

               Section 4.10 Responsibility of Trustee
The Trustee and any Conversion Agent shall not at any time be under any duty or responsibility
to any Holder of Notes to determine or calculate the Conversion Rate, to determine whether any
facts exist which may require any adjustment of the Conversion Rate, or to confirm the accuracy of
any such adjustment when made or the appropriateness of the method employed, or herein or in any
supplemental indenture provided to be employed, in making the same. The Trustee and any other
Conversion Agent shall not be accountable with respect to the validity or value (or the kind or
amount) of any shares of Common Stock or of any other securities or property that may at any time
be issued or delivered upon the conversion of any Notes; and the Trustee and the Conversion Agent
make no representations with respect thereto. Neither the Trustee nor any Conversion Agent shall
be responsible for any failure of the Company to issue, transfer or deliver any shares of Common
Stock or stock certificates or other securities or property or cash

43

 

upon the surrender of any Notes
for the purpose of conversion or to comply with any of the duties, responsibilities or covenants of
the Company contained in this Article 4. The rights, privileges, protections, immunities and
benefits given to the Trustee, including without limitation its right to be compensated,
reimbursed, and indemnified, are extended to, and shall be enforceable by, the Trustee in each of
its capacities hereunder, including its capacity as Conversion Agent and if it is so appointed by
the Company and accepts such appointment, as Bid Solicitation Agent.

               Section 4.11 Notice to Holders Prior to Certain Actions
In case of any:

     (a) action by the Company or one of its Subsidiaries that would require an adjustment in
the Conversion Rate pursuant to Section 4.04 or Section 4.12; or

     (b) Merger Event; or

     (c) voluntary or involuntary dissolution, liquidation or winding up of the Company or any
of its Subsidiaries;

then, in each case (unless notice of such event is otherwise required pursuant to another provision
of this Supplemental Indenture), the Company shall cause to be filed with the Trustee and the
Conversion Agent (if other than the Trustee) and to be mailed to each Holder of Notes at such
Holder’s address appearing in the Register, which the Company shall provide to the Trustee, except
with respect to notice periods otherwise specified in this Supplemental Indenture (in which case
such other provisions setting forth notice periods shall control) as promptly as practicable but in
any event at least 10 days prior to the applicable date hereinafter specified, a notice stating (x)
the date on which a record is to be taken for the purpose of such action by the Company or one of
its Subsidiaries or, if a record is not to be taken, the date as of which the holders of Common
Stock of record are to be determined for the purposes of such action by the Company or one of its
Subsidiaries, or (y) the date on which such Merger Event, dissolution, liquidation or winding up is
expected to become effective or occur, and the date as of which it is expected that holders of
Common Stock of record shall be entitled to exchange their Common Stock for securities or other
property deliverable upon such Merger Event, dissolution, liquidation or winding up. Failure to
give such notice, or any defect therein, shall not affect the legality or validity of such dividend
(or any other distribution), Merger Event, dissolution, liquidation or winding up.

               Section 4.12 Stockholder Rights Plan. Each share of Common Stock, if any, issued upon conversion of Notes pursuant to this
Article 4 shall be entitled to receive the appropriate number of rights, if any, and the
certificates representing the Common Stock issued upon such conversion shall bear such legends, if
any, in each case as may be provided by the terms of any stockholder rights plan adopted by the
Company and in effect upon conversion of such Notes, as the same may be amended from time to time.
Notwithstanding the foregoing, if prior to any conversion such rights have separated from the
shares of Common Stock in accordance with the provisions of the applicable stockholder rights
agreement, the Conversion Rate shall be adjusted at the time of separation as if the Company had
distributed to all holders of the Common Stock, shares of the Company’s Capital Stock, evidences of
indebtedness, assets,

44

 

property, rights, options or warrants as described in Section 4.04(c),
subject to readjustment in the event of the expiration, termination or redemption of such rights.

ARTICLE 5.

REMEDIES

               Section 5.01 Events of Default. Each of the following events shall be an “Event of Default” wherever used herein with
respect to the Notes, and, except to the extent set forth in this Section 5.01, the Notes shall not
have the benefit of any “Event of Default” specified in Section 6.1 of the Original Indenture,
which shall not apply with respect to the Notes, and this Section 5.01 supersedes the entirety
thereof:

     (a) default for 30 days in the payment when due of interest on the Notes, whether or not
prohibited by the provisions of Article 10;

     (b) default in the payment of principal of any Note when due and payable at Stated
Maturity, upon purchase in connection with a Fundamental Change, upon declaration of
acceleration or otherwise, when the same becomes due and payable, whether or not prohibited by
the provisions of Article 10;

     (c) failure by the Company to comply with its obligation to convert the Notes in
accordance with this Supplemental Indenture upon exercise of a Holder’s conversion right,
whether or not any cash payment due upon conversion is prohibited by the provisions of Article
10, and such failure continues for five Business Days following the last Business Day of the
relevant period set forth in Section 4.03(a)(3) for the settlement of such conversion;

     (d) failure by the Company to comply with its obligations under Section 8.01;

     (e) failure by the Company to provide a Fundamental Change Company Notice pursuant to
Section 3.01(b), notice of a Make-Whole Fundamental Change pursuant to Section 4.06(e) or
notice of a specified corporate transaction required by Section 4.01(b)(3) or Section
4.01(b)(4) in accordance with the relevant Section, in each case when due;

     (f) failure by the Company to comply with any of its other agreements (other than a
covenant or warranty or default in whose performance or whose breach is elsewhere in this
Section 5.01 specifically provided for) contained in the Notes or this Supplemental Indenture
for 60 days after the Company has received written notice of such default from the Trustee or
the Holders of at least 25% in principal amount of the then outstanding Notes;

     (g) default by the Company or any of its Subsidiaries with respect to any mortgage,
agreement or other instrument under which there may be outstanding, or by which there may be
secured or evidenced, any indebtedness for money borrowed in excess of $50.0 million in the
aggregate of the Company or any such Subsidiary, whether such indebtedness exists on the date
of this Supplemental Indenture or shall hereafter be created (i) resulting in such
indebtedness becoming or being declared due and payable or

45

 

(ii) constituting a failure to pay
the principal or interest of any such debt when due and payable at its stated maturity, upon
required repurchase, upon declaration or otherwise;

     (h) failure by the Company or any of its Subsidiaries to pay final judgments entered by a
court or courts of competent jurisdiction in excess of $50.0 million, which judgments are not
paid, discharged or stayed, for a period of 60 days;

     (i) the Company or any of its Significant Subsidiaries:

          (1) commences a voluntary case,

          (2) consents to the entry of an order for relief against it in an involuntary case,

          (3) consents to the appointment of a custodian of it or for all or substantially all of its
property,

          (4) makes a general assignment for the benefit of its creditors, or

          (5) generally is not paying its debts as they become due; and

     (j) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law
that:

          (1) is for relief against the Company or any of its Significant Subsidiaries in an involuntary
case;

          (2) appoints a custodian of the Company or any of its Significant Subsidiaries or for all or
substantially all of the property of the Company or any of its Significant Subsidiaries; or

          (3) orders the liquidation of the Company or any of its Significant Subsidiaries;
and the order or decree remains unstayed and in effect for 60 consecutive days.

               Section 5.02 Acceleration.
If an Event of Default (other than an Event of Default specified under Section 5.01(i) or
Section 5.01(j) with respect to the Company) occurs and is continuing, the Trustee by notice to the
Company, or the Holders of at least 25% in aggregate principal amount of then outstanding Notes by
notice to the Company and the Trustee, may, and the Trustee at the request of such Holders shall,
declare 100% of the principal of, and accrued and unpaid interest, if any, on, all then Outstanding
Notes to be due and payable. Upon such a declaration of acceleration, such principal and accrued
and unpaid interest, if any, will be due and payable immediately, subject to Section 10.04. If an
Event of Default arising under Section 5.01(i) or Section 5.01(j) with respect to the Company
occurs, the principal of, and accrued and unpaid interest on, all of the Notes shall become
immediately due and payable without any declaration or other act of the Holders or any act on the
part of the Trustee, subject to Section 10.04.

46

 

               Section 5.03 Additional Interest. Notwithstanding any provisions of the Indenture to the contrary, to the extent the Company
elects, the sole remedy for an Event of Default relating to (i) its failure to file with the
Trustee pursuant to Section 314(a)(1) of the Trust Indenture Act any documents or reports that it
is required to file with the Commission pursuant to Section 13 or 15(d) of the Exchange Act or (ii)
its failure to comply with its obligations in Section 4.4 of the Original Indenture, as modified by
Section 2.03 of this Supplemental Indenture, shall for the 364 days after the occurrence of
such an Event of Default consist exclusively of the right to receive additional interest on
the Notes at a rate equal to 0.25% per annum of the principal amount of the Notes Outstanding
(“Additional Interest”) for each day during the 180-day period beginning on, and including, the
occurrence of such an Event of Default during which such Event of Default is continuing, which such
Additional Interest shall be increased by an additional 0.25% per annum, on the 181st day after
such Event of Default (if such Event of Default is not cured or waived prior to such 181st day),
provided that the rate at which such Additional Interest accrues may in no event exceed 0.50% per
annum. If the Company so elects, such Additional Interest shall be payable in the same manner and
on the same dates as the stated interest payable on the Notes. On the 365th day after such Event
of Default occurs (if such Event of Default is not cured or waived prior to such 365th day), such
Additional Interest shall cease to accrue and the Notes shall be subject to acceleration as
provided in Section 5.02. This Section 5.03 shall not affect the rights of Holders of Notes in the
event of the occurrence of any other Event of Default. In the event the Company does not elect to
pay Additional Interest following an Event of Default in accordance with this Section 5.03, the
Notes shall be subject to acceleration as provided in Section 5.02.

     In order to elect to pay Additional Interest as the sole remedy during the first 364 days
after the occurrence of an Event of Default described in the immediately preceding paragraph, the
Company must give notice to Holders of the Notes, the Trustee and the Paying Agent of such election
prior to the beginning of such 364-day period. Upon the failure to timely give all Holders, the
Trustee and the Paying Agent such notice, the Notes shall be immediately subject to acceleration as
provided in Section 5.02.

               Section 5.04
Waiver; Unconditional Right of Holders to Receive Amounts Due Upon
Conversion. (a) The Holders of a majority in aggregate principal amount of Notes then outstanding
may, on behalf of the Holders of all Notes, waive all past Defaults (except with respect to
the Company’s (a) nonpayment of the principal of or interest on any Note, (b) failure to pay
or deliver, as the case may be, the consideration due upon conversion in accordance with
Article 4 or (c) failure to pay the Fundamental Change Purchase Price (if applicable) in
accordance with Article 3) and rescind any acceleration arising under Section 5.02 with
respect to the Notes and its consequences if:

          (1) rescission would not conflict with any judgment or decree of a court of competent
jurisdiction; and

          (2) all existing Events of Default, other than the nonpayment of the principal of and
interest, if any, on the Notes that have become due solely by such declaration of acceleration,
have been cured or waived.

47

 

     (b) In addition to the circumstances set forth in Section 6.7 of the Original Indenture
and notwithstanding any provision to the contrary in the Indenture, the Holder of any Note
shall have the right, which is absolute and unconditional, to receive amounts due upon
conversion in accordance with Article 4 and the Fundamental Change Purchase Price (if
applicable) in accordance with Article 3 and to institute suit for the enforcement of any
such payment or delivery, as the case may be, and such rights shall not be impaired
without the consent of such Holder.

               Section 5.05 Notice of Defaults. Notwithstanding any provision to the contrary in the Indenture, (a) the list of exceptions
in Section 7.5 of the Original Indenture pursuant to which the Trustee may not withhold notice of
any Default under the Indenture shall include the payment of the Fundamental Change Purchase Price
(if applicable) in accordance with Article 3 and the payment or delivery, as the case may be, of
the consideration due upon conversion of the Notes in accordance with Article 4 and (b) in addition
to any obligations of the Company under Section 7.5 of the Original Indenture, the Company shall
deliver to the Trustee, within 30 days after the occurrence thereof, written notice of any events
that would constitute an Event of Default, the status of such events and what action the Company is
taking or proposes to take in respect thereof.

               Section 5.06 Overdue Payments. Payments of (a) principal of the Notes, (b) to the extent lawful, interest on the Notes and
(c) the Fundamental Change Purchase Price (if applicable) in accordance with Article 3 that are not
made when due shall, in each case, accrue interest at the annual rate of the then-applicable
interest rate of the Notes from the required payment date (any such amounts, “Defaulted Amounts”);
provided, however, that any such payment that is required to be made on any day that is not a
Business Day will be made on the next succeeding Business Day and no interest on such payment will
accrue in respect of the delay. The Company shall pay any such Defaulted Amounts in accordance
with the provisions of Section 2.13 of the Original Indenture and, for this purpose, each reference
to Defaulted Interest in the Original Indenture shall be deemed to be a reference to Defaulted
Amounts. In addition, all references in Section 6.3 and Section 6.8 of the Original Indenture to
“principal” shall, with respect to the Notes, be deemed to be references to “principal (including
the Fundamental Change Purchase Price, if applicable)” and all references to any “Event of Default”
in Section 6.8 of the Original Indenture shall, with respect to the Notes, be deemed to be
references to any Event of Default specified in Sections 5.01(a), (b) or (c).

ARTICLE 6.

SATISFACTION AND DISCHARGE

               Section 6.01 Satisfaction and Discharge of the Supplemental Indenture. Articles VIII and XI of the Original Indenture shall not apply to the Notes. Instead, the
satisfaction and discharge provisions set forth in this Article 6 shall, with respect to the Notes,
supersede in their entirety Articles VIII and XI of the Original Indenture, and all references in
the Original Indenture to Articles VIII and XI thereof and satisfaction and discharge provisions
therein, as the case may be, shall, with respect to the Notes, be deemed to be references to this
Article 6 and the satisfaction and discharge provisions set forth in this Article 6, respectively.
When (a) the Company shall deliver to the Registrar for cancellation all Notes theretofore
authenticated (other than any Notes that have been destroyed, lost or stolen and in lieu of or in

48

 

substitution for which other Notes shall have been authenticated and delivered) and not
theretofore canceled, or (b) all the Notes not theretofore canceled or delivered to the
Trustee for cancellation shall have become due and payable (whether at Stated Maturity, on any
Fundamental Change Purchase Date, upon conversion or otherwise) and the Company shall deposit with
the Trustee, in trust, or deliver to the Holders, as applicable, shares of Common Stock, cash or
cash and shares of Common Stock (in the case of any conversion to which Physical Settlement, Cash
Settlement or Combination Settlement, respectively, applies), if any, sufficient to pay all amounts
due (and shares of Common Stock deliverable following conversion, if applicable) on all of such
Notes (other than any Notes that shall have been mutilated, destroyed, lost or stolen and in lieu
of or in substitution for which other Notes shall have been authenticated and delivered) not
theretofore canceled or delivered to the Trustee for cancellation, including principal and interest
due, accompanied, except in the event the Notes are due and payable solely in cash at the Stated
Maturity of the Notes or upon an earlier Fundamental Change Purchase Date, by a verification report
as to the sufficiency of the deposited amount from an independent certified accountant or other
financial professional reasonably satisfactory to the Trustee (which may include any of the
Underwriters), and if the Company shall also pay or cause to be paid all other sums payable
hereunder by the Company, then this Supplemental Indenture shall cease to be of further effect
(except as to (i) rights hereunder of Holders of the Notes to receive all amounts owing upon the
Notes and the other rights, duties and obligations of Holders of the Notes, as beneficiaries hereof
with respect to the amounts, if any, so deposited with the Trustee and (ii) the rights, obligations
and immunities of the Trustee hereunder), and the Trustee, on written demand of the Company
accompanied by an Officers’ Certificate and an Opinion of Counsel as required by Section 12.4 of
the Original Indenture and at the cost and expense of the Company, shall execute proper instruments
acknowledging satisfaction and discharge of this Supplemental Indenture; the Company, however,
hereby agrees to reimburse the Trustee for any costs or expenses thereafter reasonably and properly
incurred by the Trustee, including the fees and expenses of its counsel, and to compensate the
Trustee for any services thereafter reasonably and properly rendered by the Trustee in connection
with this Supplemental Indenture or the Notes.

               Section 6.02 Deposited Monies to Be Held in Trust by Trustee. Subject to Section 6.04, all monies and shares of Common Stock, if any, deposited with the
Trustee pursuant to Section 6.01 shall be held in trust for the sole benefit of the Holders of the
Notes, and such monies and shares of Common Stock shall be applied by the Trustee to the payment,
either directly or through any Paying Agent (including the Company if acting as its own Paying
Agent), to the Holders of the particular Notes for the payment, settlement or redemption of which
such monies or shares of Common Stock have been deposited with the Trustee, of all sums or amounts
due and to become due thereon for principal and interest, if any.

               Section 6.03 Paying Agent to Repay Monies Held. Upon the satisfaction and discharge of this Supplemental Indenture, all monies and shares
of Common Stock, if any, then held by any Paying Agent (if other than the Trustee) shall, upon
written request of the Company, be repaid to it or paid to the Trustee, and thereupon such Paying
Agent shall be released from all further liability with respect to such monies and shares of Common
Stock.

               Section 6.04 Return of Unclaimed Monies. Subject to the requirements of applicable law, any monies and shares of Common Stock
deposited with or paid to the Trustee

49

 

for payment of the principal of or interest, if any, on the
Notes and not applied but remaining unclaimed by the Holders of the Notes for two years after the
date upon which the principal of or interest, if any, on such Notes, as the case may be, shall have
become due and payable, shall be repaid to the Company by the Trustee on demand, and all liability
of the Trustee shall thereupon cease with respect to such monies and shares of Common Stock; and
the Holder of any of the Notes shall thereafter look only to the Company for any payment or
delivery that such Holder of the Notes may be entitled to collect unless an applicable abandoned
property law designates another person.

               Section 6.05 Reinstatement. If the Trustee or the Paying Agent is unable to apply any money or shares of Common Stock
in accordance with Section 6.02 by reason of any order or judgment of any court or governmental
authority enjoining, restraining or otherwise prohibiting such application, the Company’s
obligations under the Indenture and the Notes shall be revived and reinstated as though no deposit
had occurred pursuant to Section 6.01 until such time as the Trustee or the Paying Agent is
permitted to apply all such money and shares of Common Stock in accordance with Section 6.02;
provided, however, that if the Company makes any payment of interest on, principal of or payment or
delivery in respect of any Note following the reinstatement of its obligations, the Company shall
be subrogated to the rights of the Holders of such Notes to receive such payment from the money or
shares of Common Stock, if any, held by the Trustee or Paying Agent.

ARTICLE 7.

SUPPLEMENTAL INDENTURES

               Section 7.01 Supplemental Indentures Without Consent of Holders. In lieu of Section 9.1 of the Original Indenture, the Company and the Trustee may amend or
supplement the Indenture or the Notes without notice to or the consent of any Holder of the Notes
to:

     (a) provide for the assumption by a Successor Company of the Company’s obligations under
the Indenture;

     (b) add guarantees with respect to the Notes;

     (c) secure the Notes;

     (d) add to the Company’s covenants for the benefit of the Holders or surrender any right
or power conferred upon the Company by the Indenture;

     (e) make any change that does not adversely affect the rights of any Holder, including
without limitation curing any omission, ambiguity, manifest error or defect and correcting any
inconsistency in the Indenture;

     (f) add provisions for the issuance of Additional Notes;

     (g) comply with any requirement of the Commission in connection with the qualification of
the Indenture under the Trust Indenture Act;.

50

 

     (h) add additional Events of Default;

     (i) evidence the acceptance or appointment of a successor Trustee;

     (j) provide for uncertificated Notes in addition to or in place of certificated Notes;
provided, however, that the uncertificated Notes are issued in registered form for purposes of
Section 163(f) of the Code or in a manner such that the uncertificated Notes are described in
Section 163(f)(2)(B) of the Code; or

     (k) conform any provision of this Supplemental Indenture and the form or terms of the
Notes to the “Description of Debt Securities” section as set forth in the final prospectus
related to the offering and sale of the Notes dated August 2, 2010, as amended and
supplemented by the “Description of Notes” section as set forth in the final prospectus
supplement related to the offering and sale of the Notes dated August 3, 2010, as supplemented
by a pricing term sheet to the extent that such description was intended to be a verbatim
recitation of a provision in the Supplemental Indenture or the form or terms of the Notes.

               Section 7.02 Supplemental Indentures With Consent of Holders. Subject to certain exceptions, the Indenture or the Notes may be amended with the consent
of the Holders of at least a majority in aggregate principal amount of the Notes then Outstanding
(including, without limitation, consents obtained in connection with a purchase of, or tender offer
or exchange offer for, Notes) and, subject to certain exceptions, any past Default or compliance
with any provisions may be waived with the consent of the Holders of a majority in aggregate
principal amount of the Notes then Outstanding (including, without limitation, consents obtained in
connection with a purchase of, or tender offer or exchange offer for, Notes). In lieu of Section
9.2 of the Original Indenture, which shall not apply with respect to the Notes, without the consent
of each Holder affected thereby, no amendment, supplement or waiver, including a waiver in relation
to a past Event of Default, may:

     (a) reduce the percentage of the aggregate principal amount of then Outstanding Notes
whose Holders must consent to an amendment of the Indenture or to waive any past Default;

     (b) reduce the rate of or extend the stated time for payment of interest on any Notes;

     (c) reduce the principal of, or extend the Stated Maturity of any Notes;

     (d) make any change that adversely affects the conversion rights of any Notes;

     (e) reduce the Fundamental Change Purchase Price of any Note or amend or modify in any
manner adverse to the Holders of Notes the Company’s obligation to make any such payment,
whether through an amendment or waiver of provisions in the covenants, definitions related
thereto or otherwise;

     (f) make any Notes payable in any currency other than that stated in the Notes;

51

 

     (g) change the ranking of the Notes;

     (h) impair the right of any Holder to receive payment of principal of and interest on, or
the consideration due upon conversion of, such Holder’s Notes on or after the due dates
therefore or to institute suit for the enforcement of any payment on or with respect to such
Holder’s Notes; or

     (i) make any change to the provisions of Article 10 if such change would adversely affect
the rights of the Holders.

     The consent of the Holders is not necessary under the Indenture to approve the particular form
of any proposed amendment. It is sufficient if such consent approves the substance of the proposed
amendment.

               Section 7.03 Notice of Amendment or Supplement. After an amendment or supplement under this Article 7 or Article IX of the Original
Indenture becomes effective, the Company shall mail to the Holders a notice briefly describing such
amendment or supplement. However, the failure to give such notice to all the Holders, or any
defect in the notice, shall not impair or affect the validity of the amendment or supplement.

ARTICLE 8.

SUCCESSOR COMPANY

               Section 8.01 Consolidation, Merger and Sale of Assets. The provisions in Articles V of the Original Indenture shall not apply with respect to the
Notes, and this Article 8 supersedes the entirety thereof. The Company shall not consolidate with
or merge with or into, or sell, convey, transfer, lease or otherwise dispose of all or
substantially all of the consolidated assets of the Company and its Subsidiaries, taken as a whole,
to, another person, unless:

     (a) the resulting, surviving or transferee person (if not the Company) (the “Successor
Company”) is a corporation or limited liability company (that is treated as a corporation for
U.S. federal income tax purposes) organized and existing under the laws of the U.S., any state
thereof or the District of Columbia and such Successor Company (if not the Company) expressly
assumes by supplemental indenture all of the Company’s obligations under the Notes and the
Indenture;

     (b) if as a result of such transaction the Notes become convertible into common stock or
other securities issued by a third party, such third party fully and unconditionally
guarantees all obligations of the Company or such Successor Company under the Notes and
the Supplemental Indenture;

     (c) immediately after giving effect to such transaction, no Default or Event of Default
has occurred and is continuing under the Indenture; and

     (d) the Company has delivered to the Trustee the Officers’ Certificate and Opinion of
Counsel pursuant to Section 8.03.

52

 

               Section 8.02 Successor Person Substituted. In case of any such consolidation, merger, sale, conveyance, transfer, lease or other
disposition set forth in Section 8.01, in which the Company is not the Successor Company and upon
the assumption by the Successor Company by supplemental indenture executed and delivered to the
Trustee of the due and punctual payment of the principal of and interest on all of the Notes, and
the due and punctual performance and observance of all of the covenants and conditions of the
Indenture to be performed or satisfied by the Company, such Successor Company shall succeed to, and
be substituted for, and may exercise every right and power of, the Company under the Indenture,
with the same effect as if it had been named herein as the party of this first part, and the
Company shall be discharged from its obligations under the Notes and the Indenture, except in the
case of any such lease. Such Successor Company thereupon may cause to be signed, and may issue
either in its own name or in the name of the Company any or all of the Notes, issuable hereunder
that theretofore shall not have been signed by the Company and delivered to the Trustee; and, upon
the order of such Successor Company instead of the Company and subject to all the terms, conditions
and limitations in the Indenture prescribed, the Trustee shall authenticate and shall deliver, or
cause to be authenticated and delivered, any Notes that previously shall have been signed and
delivered by the officers of the Company to the Trustee for authentication, and any Notes that such
Successor Company thereafter shall cause to be signed and delivered to the Trustee for that
purpose. All the Notes so issued shall in all respects have the same legal rank and benefit under
the Indenture as the Notes theretofore or thereafter issued in accordance with the terms of this
Supplemental Indenture as though all of such Notes had been issued at the date of the execution
hereof. In the event of any such consolidation, merger, sale, conveyance, transfer or other
disposition upon compliance with this Article 8 the person named as the “Company” in the first
paragraph of this Supplemental Indenture or any successor that shall thereafter have become such in
the manner prescribed in this Article 8 may be dissolved, wound up and liquidated at any time
thereafter and such person shall be discharged from its liabilities as obligor and maker of the
Notes and from its obligations under the Indenture.

               Section 8.03 Opinion of Counsel to Be Given to Trustee. Prior to execution of any supplemental indenture pursuant to this Article 8, the Trustee
shall receive an Officers’ Certificate and an Opinion of Counsel in accordance with Section 12.4 of
the Original Indenture as conclusive evidence that consolidation, merger, sale, conveyance,
transfer, lease or other disposition set forth in Section 8.01 and any such assumption complies
with the provisions of this Article 8.

ARTICLE 9.

MISCELLANEOUS

               Section 9.01 Governing Law. THIS SUPPLEMENTAL INDENTURE AND EACH OF THE NOTES, AND ANY CLAIM CONTROVERSY OR DISPUTE
ARISING UNDER OR RELATED TO THIS SUPPLEMENTAL INDENTURE AND EACH OF THE NOTES, SHALL BE GOVERNED
BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK.

53

 

               Section 9.02 Legal Holidays. All references in Section 12.7 of the Original Indenture to “Repayment Date” shall, for
purposes of the Notes, be deemed to be references to “Fundamental Change Purchase Date.”

               Section 9.03 No Security Interest Created. Nothing in this Supplemental Indenture or in the Notes, expressed or implied, shall be
construed to constitute a security interest under the Uniform Commercial Code or similar
legislation, as now or hereafter enacted and in effect, in any jurisdiction.

               Section 9.04 Trust Indenture Act. This Supplemental Indenture will be subject to, and governed by, the provisions of the
Trust Indenture Act that are required to be part of this Supplemental Indenture and shall, to the
extent applicable, be governed by such provisions.

               Section 9.05 Benefits of Supplemental Indenture. Nothing in this Supplemental Indenture or in the Notes, express or implied, shall give to
any person (including any Registrar, any Paying Agent, any Conversion Agent, any Bid Solicitation
Agent and their successors hereunder), other than the parties hereto, any benefit or any legal or
equitable right, remedy or claim under this Supplemental Indenture.

               Section 9.06 Calculations. Except as otherwise provided in this Supplemental Indenture, the Company shall be
responsible for making all calculations called for under the Notes. These calculations include,
but are not limited to, determinations of the Last Reported Sale Prices of the Common Stock,
accrued interest payable on the Notes and the Conversion Rate. The Company shall make all these
calculations in good faith and, absent manifest error, the Company’s calculations shall be final
and binding on Holders of Notes. The Company shall provide a schedule of its calculations to each
of the Trustee and the Conversion Agent, and each of the Trustee and Conversion Agent is entitled
to rely conclusively upon the accuracy of the Company’s calculations without independent
verification. The Trustee will forward the Company’s calculations to any Holder of Notes upon the
request of that Holder at the sole cost and expense of the Company.

               Section 9.07 Effect of Headings and Table of Contents. The Article and Section headings herein and the Table of Contents are for convenience only
and shall not affect the construction hereof.

               Section 9.08 Execution in Counterparts. This Supplemental Indenture may be executed in any number of counterparts, each of which
shall be an original, but such counterparts shall together constitute but one and the same
instrument.

               Section 9.09 Separability Clause. In case any provision in this Supplemental Indenture or in any Note or coupon shall be
invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining
provisions shall not in any way be affected or impaired thereby.

               Section 9.10 Ratification of Original Indenture. The Original Indenture, as supplemented by this Supplemental Indenture, is in all respects
ratified and confirmed, and this Supplemental Indenture shall be deemed part of the Original
Indenture in the manner and to

54

 

the extent herein and therein provided. For the avoidance of doubt,
each of the Company and each Holder of the Notes, by its acceptance of such Notes, acknowledges and
agrees that all of the rights, privileges, protections, immunities and benefits afforded to the
Trustee under the Original Indenture are deemed to be incorporated herein, and shall be enforceable
by the Trustee hereunder, in each of its capacities hereunder as if set forth herein in full.

               Section 9.11 The Trustee. The recitals in this Supplemental Indenture are made by the Company only and not the
Trustee, and all of the provisions contained in the Original Indenture in respect of the rights,
privileges, immunities, powers and duties of the Trustee shall be applicable in respect of the
Notes and of this Supplemental Indenture as fully and with like effect as set forth in full herein.

               Section 9.12 No Recourse Against Others No director, officer, employee, incorporator or stockholder of the Company shall have any
liability for any obligations of the Company under the Notes, the Indenture or any claim based on,
in respect of, or by reason of, such obligations or their creation. Each Holder of Notes by
accepting a Note waives and releases all such liability. The waiver and release are part of the
consideration for issuance of the Notes.

ARTICLE 10.

SUBORDINATION

               Section 10.01 Agreement to Subordinate. The Company agrees, and each Holder by accepting a Note agrees, that the Indebtedness
evidenced by the Notes is subordinated in right of payment, to the extent and in the manner
provided in this Article 10, to the prior payment in full of all Senior Indebtedness (whether
outstanding on the date hereof or hereafter created, incurred, assumed or guaranteed), and that the
subordination is for the benefit of the holders of Senior Indebtedness.

               Section 10.02 Liquidation; Dissolution; Bankruptcy Upon any distribution to creditors of the Company in a liquidation or dissolution of the
Company or in a bankruptcy, reorganization, insolvency, receivership or similar proceeding relating
to the Company or its property, in an assignment for the benefit of creditors or any marshaling of
the Company’s assets and liabilities:

          (1) holders of Senior Indebtedness will be entitled to receive payment in full of all
Obligations due in respect of such Senior Indebtedness (including interest after the commencement
of any bankruptcy proceeding at the rate specified in the applicable Senior Indebtedness) before
the Holders of Notes will be entitled to receive any payment with respect to the Notes; and

          (2) until all Obligations with respect to Senior Indebtedness (as provided in clause (1)
above) are paid in full, any distribution to which Holders would be entitled but for this Article
10 will be made to holders of Senior Indebtedness, as their interests may appear.

55

 

     (b) To the extent any payment of Senior Indebtedness is declared to be fraudulent or
preferential, set aside or required to be paid to any receiver, trustee in bankruptcy,
liquidating trustee, agent or other similar person under any bankruptcy, reorganization,
insolvency, receivership or similar proceeding, the Senior Indebtedness or part thereof
originally intended to be satisfied shall be deemed to be reinstated and outstanding as if
such payment had not occurred and the provisions of this Article 10 will be applied
accordingly.

               Section 10.03
Default on Designated Senior Indebtedness. (a) The Company may not make, directly or indirectly through any Subsidiary or other
person, any payment or distribution to the Trustee or any Holder in respect of Obligations
with respect to the Notes and may not acquire from the Trustee or any Holder any Notes for
cash or property until all principal and other Obligations with respect to the Senior
Indebtedness have been paid in full if:

          (1) a default in the payment of principal, premium, if any, interest or any other Obligation
due on any Designated Senior Indebtedness (a “Payment Default”) occurs and is continuing
(including, without limitation, a payment that has become due as a result of the acceleration of
any Designated Senior Indebtedness); or

          (2) any other default (a “Nonpayment Default”) occurs and is continuing on any series of
Designated Senior Indebtedness that permits holders of that series of Designated
Senior Indebtedness to accelerate its maturity and the Trustee receives a notice of such
default (a “Payment Blockage Notice”) from the Company or a Representative of such holders. The
Trustee shall promptly deliver a copy of any Payment Blockage Notice received by it to the Company
and the Company shall promptly deliver such copy to all holders of Designated Senior Indebtedness.
If the holders of a majority in principal amount of all Designated Senior Indebtedness outstanding
at the time such Payment Blockage Notice is delivered to the Company shall, within 10 days of their
receipt thereof, deliver to the Company and the Trustee a notice rescinding such Payment Blockage
Notice, such Payment Blockage Notice shall be deemed not to have been delivered for all purposes of
the Indenture. If the Trustee receives any such Payment Blockage Notice, no subsequent Payment
Blockage Notice will be effective for purposes of this Section 10.03 unless and until at least 360
days have elapsed since the delivery of the immediately prior Payment Blockage Notice.

     No Nonpayment Default that existed or was continuing on the date of delivery of any Payment
Blockage Notice to the Trustee may be, or may be made, the basis for a subsequent Payment Blockage
Notice unless such default has been cured or waived for a period of not less than 90 days.

     (b) The Company may and will resume payments on and distributions in respect of the Notes
and may acquire them upon the earlier of:

          (1) in the case of a Payment Default, upon the date upon which such default is cured or
waived, and

56

 

          (2) in the case of a Nonpayment Default, upon the earlier of the date on which such Nonpayment
Default is cured or waived or 179 days after the date on which the applicable Payment Blockage
Notice is received, unless the maturity of any Designated Senior Indebtedness has been accelerated
(in which event the foregoing subclause (1) shall apply),

if this Article 10 otherwise permits such payment, distribution or acquisition at the time of such
payment, distribution or acquisition.

               Section 10.04 Acceleration of Notes. If payment of the Notes is accelerated because of an Event of Default, the Company may not
make, directly or indirectly through any Subsidiary or other person, any payment or distribution to
the Trustee or any Holder in respect of Obligations with respect to the Notes and may not acquire
from the Trustee or any Holder any Notes for cash or property until all principal and other
Obligations with respect to the Senior Indebtedness have been paid in full or such acceleration is
rescinded in accordance with the terms of this Supplemental Indenture. The Company will promptly
notify holders of Senior Indebtedness of any such acceleration.

               Section 10.05 When Distribution Must Be Paid Over. In the event that the Trustee or any Holder of the Notes receives any payment of any
Obligations with respect to the Notes at a time when the payment is prohibited by Section 10.03 or
Section 10.04, such payment will be held by the Trustee or such Holder, in trust for the benefit
of, and will be paid forthwith over and delivered, upon written request, to, the holders of Senior
Indebtedness as their interests may appear or their Representative, if any, under the
agreement, indenture or other document (if any) pursuant to which Senior Indebtedness may have been
issued, as their respective interests may appear, for application to the payment of all Obligations
with respect to Senior Indebtedness remaining unpaid to the extent necessary to pay such
Obligations in full in accordance with their terms, after giving effect to any concurrent payment
or distribution to or for the holders of Senior Indebtedness.

     With respect to the holders of Senior Indebtedness, the Trustee undertakes to perform only
those obligations on the part of the Trustee as are specifically set forth in this Article 10, and
no implied covenants or obligations with respect to the holders of Senior Indebtedness will be read
into this Supplemental Indenture against the Trustee. The Trustee will not be deemed to owe any
fiduciary duty to the holders of Senior Indebtedness, and will not be liable to any such holders if
the Trustee pays over or distributes to or on behalf of Holders or the Company or any other person
money or assets to which any holders of Senior Indebtedness are then entitled by virtue of this
Article 10, except if such payment is made as a result of the willful misconduct or gross
negligence of the Trustee.

               Section 10.06 Notice by Company. The Company will promptly notify the Trustee and the Paying Agent of any facts known to the
Company that would cause a payment of any Obligations with respect to the Notes to violate this
Article 10, but failure to give such notice will not affect the subordination of the Notes to the
Senior Indebtedness as provided in this Article 10.

               Section 10.07 Subrogation. After all Senior Indebtedness is paid in full and until the Notes are paid in full, Holders
of Notes will be subrogated (equally and ratably with

57

 

all other Indebtedness pari passu with the
Notes) to the rights of holders of Senior Indebtedness to receive distributions applicable to
Senior Indebtedness to the extent that distributions otherwise payable to the Holders of Notes have
been applied to the payment of Senior Indebtedness. A distribution made under this Article 10 to
holders of Senior Indebtedness that otherwise would have been made to Holders of Notes is not, as
between the Company and Holders, a payment by the Company on the Notes.

               Section 10.08 Relative Rights. This Article 10 defines the relative rights of Holders of Notes and holders of Senior
Indebtedness. Nothing in this Supplemental Indenture will:

          (1) impair, as between the Company and Holders of Notes, the obligation of the Company, which
is absolute and unconditional, to pay principal of, and interest, if any, on, the Fundamental
Change Repurchase Price of, and to pay or deliver any amount due upon conversion of, the Notes in
accordance with their terms;

          (2) affect the relative rights of Holders of Notes and creditors of the Company other than
their rights in relation to holders of Senior Indebtedness; or

          (3) prevent the Trustee or any Holder of Notes from exercising its available remedies upon a
Default or Event of Default, subject to the rights of holders and owners of Senior Indebtedness to
receive distributions and payments otherwise payable to Holders of Notes.

     If the Company fails because of this Article 10 to pay principal of, or interest, if any, on,
the Fundamental Change Repurchase Price of, or to pay or deliver any amount due upon conversion of,
the Notes in accordance with their terms, the failure is still a Default or Event of Default.

               Section 10.09 Subordination May Not Be Impaired by Company. No right of any holder of Senior Indebtedness to enforce the subordination of the
Indebtedness evidenced by the Notes may be impaired by any act or failure to act by the Company or
any Holder or by the failure of the Company or any Holder to comply with this Supplemental
Indenture.

               Section 10.10 Distribution or Notice to Representative or Holders of Senior Indebtedness. Whenever a distribution is to be made or a notice given to holders of any series of Senior
Indebtedness, the distribution may be made and the notice given to their Representative, if they
have appointed one, and if no Representative has been appointed by the holders of any series of
Senior Indebtedness, such distribution or notice shall be made or given directly to such holders.

     Upon any payment or distribution of assets of the Company referred to in this Article 10, the
Trustee and the Holders of Notes will be entitled to rely upon any order or decree made by any
court of competent jurisdiction or upon any certificate of such Representative or of the
liquidating trustee or agent or other person making any distribution to the Trustee or to the
Holders of Notes for the purpose of ascertaining the persons entitled to participate in such
distribution, the holders of the Senior Indebtedness and other Indebtedness of the Company, the

58

 

amount thereof or payable thereon, the amount or amounts paid or distributed thereon and all other
facts pertinent thereto or to this Article 10.

               Section 10.11 Rights of Trustee and Paying Agent. Notwithstanding the provisions of this Article 10 or any other provision of the Indenture,
the Trustee will not be charged with knowledge of the existence of any facts that would prohibit
the making of any payment or distribution by the Trustee, and the Trustee and the Paying Agent may
continue to make payments on the Notes, unless the Trustee has received at its Corporate Trust
Office at least three Business Days prior to the date of such payment written notice of facts that
would cause the payment of any Obligations with respect to the Notes to violate this Article 10,
except for any acceleration of the Notes prior to making any such payment or distribution which is
known by any officer of the Trustee prior to making any such payment or distribution. The notice
may only be given by the Company or a Representative. For the avoidance of doubt, no such notice
shall constitute a Payment Blockage Notice unless
delivered in accordance with Section 10.03(a)(2). Nothing in this Article 10 will impair the
claims of, or payments to, the Trustee under or pursuant to Section 7.7 of the Original Indenture.

     The Trustee in its individual or any other capacity may hold Senior Indebtedness with the same
rights it would have if it were not Trustee. Any Registrar, any Paying Agent, any Conversion
Agent, any Bid Solicitation Agent and their successors hereunder may do the same with like rights.

               Section 10.12 Authorization to Effect Subordination; Filing Proof of Claim. Each Holder of Notes, by the Holder’s acceptance thereof, authorizes and directs the
Trustee on such Holder’s behalf to take such action as may be necessary or appropriate to
effectuate the subordination as provided in this Article 10, and appoints the Trustee to act as
such Holder’s attorney-in-fact for any and all such purposes. If the Trustee does not file a
proper proof of claim or proof of debt in the form required in any proceeding referred to in
Section 6.9 of the Original Indenture at least 30 days before the expiration of the time to file
such claim or any Representative, are hereby authorized to file an appropriate claim for and on
behalf of the Holders of the Notes.

               Section 10.13 Reliance and Amendments

     (a) Each Holder of Notes by its acceptance thereof acknowledges and agrees that the
subordination provisions set forth in this Article 10 are, and are intended to be, an
inducement and a consideration for each holder of any Senior Indebtedness, whether such Senior
Indebtedness was created or acquired before or after the issuance of the Notes, to acquire and
continue to hold, or to continue to hold, such Senior Indebtedness, and such holder of Senior
Indebtedness shall be deemed conclusively to have relied on such subordination provisions in
acquiring and continuing to hold or in continuing to hold such Senior Indebtedness.

     (b) The provisions of this Article 10 may not be amended or modified without the written
consent of the holders of all Senior Indebtedness. In addition, any amendment to, or waiver
of, the provisions of this Article 10 that adversely affects the rights of the

59

 

Holders of the
Notes will require the consent of the Holders of a majority in aggregate principal amount of
Notes then Outstanding.

               Section 10.14 No Layering The Company will not incur, create, issue, assume, guarantee or otherwise become liable for
any Indebtedness that is contractually subordinated or junior in right of payment to any Senior
Indebtedness and senior in right of payment to the Notes. No such Indebtedness will be considered
to be contractually subordinated or junior in right of payment to any Senior Indebtedness by virtue
of being unsecured or by virtue of being secured on a junior priority basis.

               Section 10.15 No Waiver of Subordination Provisions. Without in any way limiting the generality of Section 10.09, the holders of Senior
Indebtedness may, at any time and from time to time, without the consent of or notice to the
Trustee or the Holders, without incurring responsibility to the Holders and without impairing or
releasing the subordination provided in this Article 10 or the obligations hereunder of the Holders
to the holders of Senior Indebtedness, do any one or more of the following: (a) change the manner,
place or terms of payment or extend the time of payment of, or renew or alter, Senior Indebtedness,
or otherwise amend or supplement in any manner Senior Indebtedness or any instrument evidencing the
same or any agreement under which Senior Indebtedness is outstanding; (b) sell, exchange, release
or otherwise deal with any property pledged, mortgaged or otherwise securing Senior Indebtedness;
(c) release any person liable in any manner for the collection of Senior Indebtedness; and (d)
exercise or refrain from exercising any rights against the Company and any other person.

[Remainder of the page intentionally left blank]

60

 

     IN WITNESS WHEREOF, the parties hereto have caused this First Supplemental Indenture to be
duly executed as of the day and year first above written.

	 	 	 	 	 
	 	TELEFLEX INCORPORATED

 	 
	 	By:  	/s/
C. Jeffrey Jacobs 	 
	 	 	Name:  	C. Jeffrey Jacobs	 
	 	 	Title:  	Treasurer	 
	 

 

 

	 	 	 	 	 
	 	WELLS FARGO BANK, N.A., as Trustee

 	 
	 	By:  	/s/
Richard Prokosch	 
	 	 	Name:  	Richard Prokosch	 
	 	 	Title:  	Vice President	 
	 

 

 

SCHEDULE A

     The following table sets forth the number of Additional Shares by which they Conversion Rate
shall be increased pursuant to Section 4.06 based on the Stock Price and Effective Date set forth
below.

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	Stock Price	 
	Effective Date	 	$53.32	 	 	$55.00	 	 	$60.00	 	 	$65.00	 	 	$70.00	 	 	$80.00	 	 	$90.00	 	 	$100.00	 	 	$120.00	 	 	$140.00	 	 	$160.00	 	 	$180.00	 
	August 9, 2010
	 	 	2.4462	 	 	 	2.3988	 	 	 	1.8223	 	 	 	1.4229	 	 	 	1.1561	 	 	 	0.7968	 	 	 	0.5412	 	 	 	0.3503	 	 	 	0.1375	 	 	 	0.0542	 	 	 	0.0248	 	 	 	0.0075	 
	August 1, 2011
	 	 	2.4462	 	 	 	2.2671	 	 	 	1.6831	 	 	 	1.2788	 	 	 	1.0186	 	 	 	0.7023	 	 	 	0.4689	 	 	 	0.2975	 	 	 	0.1053	 	 	 	0.0337	 	 	 	0.0093	 	 	 	0.0000	 
	August 1, 2012
	 	 	2.4186	 	 	 	2.1625	 	 	 	1.5680	 	 	 	1.1563	 	 	 	0.8944	 	 	 	0.6024	 	 	 	0.4000	 	 	 	0.2501	 	 	 	0.0824	 	 	 	0.0237	 	 	 	0.0042	 	 	 	0.0000	 
	August 1, 2013
	 	 	2.3672	 	 	 	2.1010	 	 	 	1.4760	 	 	 	1.0431	 	 	 	0.7621	 	 	 	0.5051	 	 	 	0.3283	 	 	 	0.2038	 	 	 	0.0610	 	 	 	0.0135	 	 	 	0.0000	 	 	 	0.0000	 
	August 1, 2014
	 	 	2.3591	 	 	 	2.0756	 	 	 	1.4063	 	 	 	0.9483	 	 	 	0.6473	 	 	 	0.3811	 	 	 	0.2430	 	 	 	0.1443	 	 	 	0.0353	 	 	 	0.0012	 	 	 	0.0000	 	 	 	0.0000	 
	August 1, 2015
	 	 	2.3794	 	 	 	2.0643	 	 	 	1.3271	 	 	 	0.8247	 	 	 	0.4993	 	 	 	0.2336	 	 	 	0.1322	 	 	 	0.0626	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 
	August 1, 2016
	 	 	2.4462	 	 	 	2.0944	 	 	 	1.2521	 	 	 	0.7020	 	 	 	0.3644	 	 	 	0.1198	 	 	 	0.0638	 	 	 	0.0228	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 
	August 1, 2017
	 	 	2.4462	 	 	 	1.8734	 	 	 	0.3582	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 

 

 

EXHIBIT A

[FORM OF FACE OF NOTE]

THIS NOTE IS A GLOBAL NOTE WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS
REGISTERED IN THE NAME OF A DEPOSITORY OR A NOMINEE OF A DEPOSITORY. THIS NOTE IS EXCHANGEABLE FOR
NOTES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITORY OR ITS NOMINEE ONLY IN THE
LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND NO TRANSFER OF THIS NOTE (OTHER THAN A
TRANSFER OF THIS NOTE AS A WHOLE BY THE DEPOSITORY TO A NOMINEE OF THE DEPOSITORY OR BY A NOMINEE
OF THE DEPOSITORY TO THE DEPOSITORY OR ANOTHER NOMINEE OF THE DEPOSITORY) MAY BE REGISTERED EXCEPT
IN LIMITED CIRCUMSTANCES.

UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A
NEW YORK CORPORATION (“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR
PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS
REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR
TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE
OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE
REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

A-1

 

TELEFLEX INCORPORATED

3.875% Convertible Senior Subordinated Note due 2017

	 	 	No.
[             ]

CUSIP No. 879369AA4

     TELEFLEX INCORPORATED, a Delaware corporation (herein called the “Company”, which term
includes any successor person under the Indenture hereinafter referred to), for value received,
hereby promises to pay CEDE & CO., or registered assigns, [     ] MILLION DOLLARS ($[     ]) (or such lesser principal amount as shall be reflected in the books and records of the Trustee
and Depository) on August 1, 2017 unless earlier converted or repurchased, and to pay interest
thereon as set forth in the manner, at the rates and to the persons set forth in the Indenture.

     This Note shall bear interest at a rate of 3.875% per annum from August 9, 2010 or from the
most recent date to which interest had been paid or provided to, but excluding, the next scheduled
Interest Payment Date, until the principal hereof shall be repaid. Interest on this Note will be
computed on the basis of a 360-day year composed of twelve 30-day months. Interest is payable
semi-annually in arrears on each February 1 and August 1, commencing on February 1, 2011, to the
person in whose name this Note (or one or more predecessor securities) is registered at the close
of business on the Regular Record Date for such interest. Any payment that is required to be made
on any day that is not a Business Day will be made on the next succeeding Business Day and no
interest on such payment will accrue in respect of the delay. Additional Interest will be payable
at the option of the Company on the terms set forth in Section 5.03 of the within-mentioned
Supplemental Indenture, and any reference to interest on, or in respect of, any Note therein shall
be deemed to include Additional Interest if, in such context, Additional Interest is, was or would
be payable pursuant to such Section 5.03 and any express mention of the payment of Additional
Interest in any provision therein shall not be construed as excluding Additional Interest in those
provisions thereof where such express mention is not made. The Notes will not have the benefit of
Article XIII of the Original Indenture.

     The Company will pay interest on overdue principal (including the Fundamental Change Purchase
Price, if applicable), and, to the extent lawful, on Defaulted Amounts, in each case at the annual
rate of the then-applicable interest rate from the required payment date. Interest not paid when
due and any interest on principal (including the Fundamental Change Purchase Price, if applicable)
or interest not paid when due shall be paid to Holders by the Company in accordance with the
provisions of Section 5.06 of the Supplemental Indenture.

     The Company shall pay principal of and interest on this Note, so long as such Note is a Global
Note, in immediately available funds to the Depository or its nominee, as the case may be, as the
registered Holder of such Note. As provided in and subject to the provisions of the Indenture, the
Company shall pay principal of any Notes (other than Notes that are Global Notes) at the office or
agency designated by the Company for that purpose. The Company has initially designated the
Trustee as its Paying Agent and Registrar in respect of the Notes and its agency in New York, New
York as a place where Notes may be presented for payment or for registration of transfer.

A-2

 

     Reference is hereby made to the further provisions of this Note set forth on the reverse
hereof, which further provisions shall for all purposes have the same effect as if set forth at
this place.

     In the case of any conflict between this Note and the Indenture, the provisions of the
Indenture shall control. This Note, and any claim or controversy or dispute arising under or
related to this Note, shall be governed by, and construed in accordance with, the laws of the State
of New York.

     Unless the certificate of authentication hereon has been executed by the Trustee referred to
on the reverse hereof by manual signature, this Note shall not be entitled to any benefit under the
Indenture or be valid or obligatory for any purpose.

[Remainder of page intentionally left blank]

A-3

 

     IN WITNESS WHEREOF, TELEFLEX INCORPORATED has caused this instrument to be signed
manually or by facsimile by two of its duly authorized Officers.

     Dated: [          ]

	 	 	 	 	 
	 	TELEFLEX INCORPORATED

 	 
	 
	 
	 
	 	By:  	              
                            
                            

	 	 	Name:  	 	 
	 	 	Title:  
	 
	 
	 
	 	By:  	              
                            
                            
	 
	 	 	Name:  	 	 
	 	 	Title:  

A-4

 

	 	 	 	 	 

TRUSTEE’S CERTIFICATE OF AUTHENTICATION

     WELLS FARGO BANK, N.A., as Trustee, certifies that this is one of the Notes referred to in the
within-mentioned Indenture.

Dated:

WELLS FARGO BANK, N.A., as Trustee

By:                
                            
                            

Authorized Signatory

A-5

 

[FORM OF REVERSE OF NOTE]

TELEFLEX INCORPORATED

3.875% Convertible Senior Subordinated Note due 2017

     This Note is one of a duly authorized issue of Securities of the Company (herein called the
“Notes”), issued under an Indenture dated as of August 2, 2010, as previously amended and
supplemented from time to time in accordance with the terms thereof (herein called the “Original
Indenture”) and as further supplemented by the First Supplemental Indenture dated as of August 9,
2010 (herein called the “Supplemental Indenture” and the Original Indenture, as supplemented by the
Supplemental Indenture, the “Indenture”) by and between the Company and Wells Fargo Bank, N.A.,
herein called the “Trustee”, and reference is hereby made to the Indenture for a statement of the
respective rights, limitations of rights, duties and immunities thereunder of the Company, the
Trustee and the Holders of the Notes and of the terms upon which the Notes are, and are to be,
authenticated and delivered. Additional Notes may be issued in an unlimited aggregate principal
amount, subject to certain conditions specified in the Indenture.

     This Note is not subject to redemption at the option of the Company prior to August 1, 2017
and, for the avoidance of doubt, this Note is not subject to the provisions of Article III of the
Original Indenture.

     The provisions in Articles VIII and XI of the Original Indenture shall not apply with respect
to the Notes, and Article 6 of the Supplemental Indenture supersedes the entirety thereof.

     The payment of principal, accrued and unpaid interest, if any, and payment of the Fundamental
Change Purchase Price on the Notes are subordinated, to the extent and in the manner provided in
Article 10 of the Supplemental Indenture, to the prior payment in full of all Senior Indebtedness
of the Company, including Senior Indebtedness of the Company incurred after the date of the
Indenture.

     As provided in and subject to the provisions of the Indenture, upon the occurrence of a
Fundamental Change, the Holder has the right, at such Holder’s option, to require the Company to
purchase all of such Holder’s Notes or any portion thereof (in principal amounts of $1,000 or
integral multiples thereof) on the Fundamental Change Purchase Date at a price equal to the
Fundamental Change Purchase Price.

     As provided in and subject to the provisions of the Indenture, the Holder hereof has the
right, at its option (i) during certain periods and upon the occurrence of certain conditions
specified in the Indenture, prior to the close of business on the Business Day immediately
preceding May 1, 2017, and (ii) on or after May 1, 2017, at any time prior to the close of business
on the second Scheduled Trading Day immediately preceding the Stated Maturity, to convert this Note
or a portion thereof that is $1,000 or an integral multiple thereof, into cash, shares of Common
Stock or a combination thereof, at the Company’s election, at the applicable Conversion Rate
specified in the Indenture, as adjusted from time to time and under certain circumstances as
provided in the Indenture.

A-6

 

     As provided in and subject to the provisions of the Indenture, the Company will make all
payments in respect of the Fundamental Change Purchase Price and the principal amount on the Stated
Maturity thereof, as the case may be, to the holder who surrenders a Note to the Paying Agent to
collect such payments in respect of the Note. The Company will pay cash amounts in money of the
U.S. that at the time of payment is legal tender for payment of public and private debts.

     The Indenture permits, with certain exceptions as therein provided, the amendment thereof and
the modification of the rights and obligations of the Company and the rights of the Holders of the
Notes to be effected under the Indenture at any time by the Company and the Trustee with the
consent of the Holders of a majority in principal amount of the Notes at the time Outstanding. The
Indenture also contains provisions permitting the Holders of specified percentages in principal
amount of the Notes at the time Outstanding, on behalf of the Holders of all Notes, to waive
compliance by the Company with certain provisions of the Indenture and certain past Defaults under
the Indenture and their consequences. Any such consent or waiver by the Holder of this Note shall
be conclusive and binding upon such Holder and upon all future Holders of this Note and of any Note
issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether
or not notation of such consent or waiver is made upon this Note.

     As provided in and subject to the provisions of the Indenture, in case certain Events of
Default, as defined in the Indenture, shall have occurred and be continuing, the principal of and
interest on all Notes may be declared due and payable, by either the Trustee or Holders of at least
25% in aggregate principal amount of Notes then Outstanding, and upon said declaration shall become
due and payable, in the manner, with the effect and subject to the conditions provided in the
Indenture.

     No reference herein to the Indenture and no provision of this Note or of the Indenture shall
alter or impair the obligation of the Company, which is absolute and unconditional, to pay or
deliver, as the case may be, the principal of (including the Fundamental Change Purchase Price),
interest on and the consideration due upon conversion of, this Note at the time, place and rate,
and in the coin and currency, herein prescribed.

     As provided in the Indenture and subject to certain limitations therein set forth, the
transfer of this Note is registrable in the Register, upon surrender of this Note for registration
of transfer at the office or agency of the Company in any place where the principal of and interest
on this Note are payable, duly endorsed by, or accompanied by a written instrument of transfer in
form satisfactory to the Company and the Registrar duly executed by, the Holder hereof or its
attorney duly authorized in writing, and thereupon one or more new Notes of this series and of like
tenor, of authorized denominations and for the same aggregate principal amount, will be issued to
the designated transferee or transferees.

     The Notes are issuable only in registered form without coupons in denominations of $1,000 and
any integral multiple thereof. As provided in the Indenture and subject to certain limitations
therein set forth, the Notes are exchangeable for a like aggregate principal amount of Notes and of
like tenor of a different authorized denomination, as requested by the Holder surrendering the
same.

A-7

 

     No service charge shall be made for any such registration of transfer or exchange, but the
Company may require payment of a sum sufficient to cover any tax or other governmental charge
payable in connection therewith.

     Prior to due presentment of this Note for registration of transfer, the Company, the Trustee
and any agent of the Company or Trustee may treat the person in whose name the Note is registered
as the owner hereof for all purposes, whether or not this Note be overdue, and neither the Company,
the Trustee nor any such agent shall be affected by notice to the contrary. All defined terms used
in this Note that are defined in the Indenture shall have the meanings assigned to them in the
Indenture.

A-8

 

ABBREVIATIONS

The following abbreviations, when used in the inscription of the face of this Note, shall be
construed as though they were written out in full

	 	 	 

	TEN COM — as tenants in common

	 	UNIF GIFT MIN
ACT           Custodian

	 

	 	(Cust)
	 
	TEN ENT — as tenants by the entireties

	 	              
                            
                            

(Minor)
	 
	JT TEN — as joint tenants with right of
Survivorship and not as tenants in common

	 	Uniform Gifts to Minors Act ____________(State)

Additional abbreviations may also be used though not in the above list.

A-9

 

ATTACHMENT 1

[FORM OF NOTICE OF CONVERSION]

To: Teleflex Incorporated

The undersigned owner of this Note hereby irrevocably exercises the option to convert this Note, or
a portion hereof (which is $1,000 or an integral multiple hereof) below designated, into cash,
shares of Common Stock or a combination of cash and shares of Common Stock, at the Company’s
election, in accordance with the terms of the Indenture referred to in this Note, and directs that
cash payable and any shares of Common Stock issuable and deliverable upon conversion, together with
any cash in payment for fractional shares of Common Stock, and any Notes representing any
unconverted principal amount hereof, be paid or issued and delivered, as the case may be, to the
registered Holder hereof unless a different name has been indicated below. Subject to certain
exceptions set forth in the Indenture, if this notice is being delivered on a date after the close
of business on a Regular Record Date and prior to the open of business on the related Interest
Payment Date, this notice is accompanied by payment of an amount equal to the interest payable on
such Interest Payment Date of the principal of this Note to be converted. If any shares of Common
Stock are to be issued in the name of a person other than the undersigned, the undersigned will pay
all transfer taxes payable with respect hereto as set forth in Section 4.08 of the Supplemental
Indenture. Any amount required to be paid by the undersigned on account of interest accompanies
this Note.

Principal amount to be converted (in an integral multiple of $1,000, if less than all):

	 	 	 	 	 
	 	 	 
	 	 	 	 	 
	 	 	 
	 	Signature(s)
	 	 	 	 	 
	 	 	 	 	 
	 	Signature(s) must be guaranteed by an
institution which is a
member of one of the following recognized signature Guarantee
Programs:

(i) The Securities Transfer Agent Medallion Program (STAMP);

(ii) The New York Stock Exchange Medallion Program (MNSP);

(iii) The Stock Exchange Medallion Program (SEMP) or

(iv) another guarantee program acceptable to the Trustee.
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 
	 	 	 	 	 
	 	 	 
	 	Signature Guarantee	 

A-10

 

	 	 	 	 	 

Fill in for registration of any shares of Common Stock and Notes if to be issued otherwise
than to the registered Holder.

 

 

 

————————————————————————

(Name)

 

————————————————————————

(Address)

 

Please print Name and Address

(including zip code number)

 

Social Security or other Taxpayer

Identifying Number ______________________________

A-11

 

ATTACHMENT 2

[FORM OF FUNDAMENTAL CHANGE PURCHASE NOTICE]

To: Teleflex Incorporated

The undersigned registered owner of this Note hereby acknowledges receipt of a notice from Teleflex
Incorporated (the “Company”) as to the occurrence of a Fundamental Change with respect to the
Company and specifying the Fundamental Change Purchase Date and requests and instructs the Company
to pay to the registered holder hereof in accordance with the applicable provisions of this Note
and the Indenture referred to in this Note (1) the entire principal amount of this Note, or the
portion thereof (that is $1,000 principal amount or an integral multiple thereof) below designated,
and (2) if such Fundamental Change Purchase Date does not fall during the period after a Regular
Record Date and on or prior to the corresponding Interest Payment Date, accrued and unpaid interest
thereon to, but excluding, such Fundamental Change Purchase Date.

In the case of certificated Notes, the certificate numbers of the Notes to be repurchased are as
set forth below:

Dated: _______________

	 	 	 
	 	Signature(s)	 
	 
	 	 	 
	 	Social Security or Other Taxpayer Identification
Number
	 
	 	principal
amount to be repaid (if less than all):
$             
,000
	 
	 	NOTICE: The signature on the Fundamental Change
Purchase

Notice must correspond with the name as written upon the face
of the Note in every particular without alteration or
enlargement or any change whatever.
 	 

A-12

 

	 	 	 	 	 

ATTACHMENT 3

[FORM OF ASSIGNMENT AND TRANSFER]

     For
value received
             hereby sell(s), assign(s) and transfer(s)
unto
             (Please insert social security or Taxpayer Identification
Number of assignee) the within Note, and hereby irrevocably constitutes and appoints
            
to transfer the said Note on the books of the Company, with full power of
substitution in the premises.

	 	 	 
	 	 	 
	 
	 	 	 
	 	Signature(s)
	 
	 	Signature(s) must be guaranteed by an
institution which is a member of one of the following recognized
signature Guarantee Programs:
	 
	 	(i) The Securities Transfer Agent Medallion Program (STAMP);

(ii) The New York Stock Exchange Medallion Program (MNSP);

(iii) The Stock Exchange Medallion Program (SEMP) or

(iv) another guarantee	 

A-13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}]]